data_5xk4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5xk4 _Structure_validation_residue.Date_analyzed 2017-06-23 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.62 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.62 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.1 mtp85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 t30 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 68' ' ' HIS . 1.2 p . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 66' ' ' THR . 17.6 m170 -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD13 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.2 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.524 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 30.9 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.496 ' C ' ' HD1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.458 ' H ' HD11 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.528 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.528 ' CD ' HH11 ' A' ' 42' ' ' ARG . 22.0 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.447 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 61' ' ' ILE . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 23' ' ' ILE . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 10' ' ' GLY . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.597 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.597 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.552 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 8.6 t30 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' THR . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 7' ' ' THR . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.639 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.639 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 66' ' ' THR . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.463 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.932 0.396 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.456 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.456 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' OG1' ' A' ' 7' ' ' THR . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.984 0.421 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.657 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.657 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HZ1' ' CG2' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 61' ' ' ILE . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.447 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 121.012 0.434 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.645 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.645 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.515 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 23' ' ' ILE . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.7 t30 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' C ' HE21 ' A' ' 31' ' ' GLN . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.531 HE21 ' C ' ' A' ' 27' ' ' LYS . 48.0 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 67' ' ' LEU . 12.8 t . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.639 ' H ' ' HG1' ' A' ' 66' ' ' THR . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.983 0.421 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 7' ' ' THR . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.659 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.659 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.678 ' HE ' ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.678 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 39.2 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.542 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.435 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' H ' ' HG1' ' A' ' 66' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 66' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.65 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.988 0.423 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.649 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.649 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.63 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.63 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 97.4 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.467 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.404 HD13 ' H ' ' A' ' 70' ' ' VAL . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.404 ' H ' HD13 ' A' ' 69' ' ' LEU . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.602 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' C ' HD21 ' A' ' 25' ' ' ASN . 0.1 OUTLIER -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 61' ' ' ILE . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 63' ' ' LYS . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 61' ' ' ILE . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 66' ' ' THR . 5.2 m-70 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.438 ' H ' HD11 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 7' ' ' THR . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.645 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.645 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' NZ ' ' CB ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.627 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.627 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.708 ' HG1' ' NE2' ' A' ' 68' ' ' HIS . 1.1 p . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.708 ' NE2' ' HG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 7' ' ' THR . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' NZ ' ' CD1' ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HG1' ' CE1' ' A' ' 68' ' ' HIS . 1.1 p . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' CE1' ' HG1' ' A' ' 66' ' ' THR . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.422 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.94 0.4 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.625 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.625 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 HD13 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' H ' HD13 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' GLY . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.639 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' N ' ' CD1' ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 34.5 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' NE2' ' A' ' 68' ' ' HIS . 1.4 p . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' NE2' ' HG1' ' A' ' 66' ' ' THR . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 ' H ' HD11 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 121.004 0.431 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.642 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.501 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.501 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 64.6 t30 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' CG2' HE22 ' A' ' 41' ' ' GLN . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.628 HE22 ' N ' ' A' ' 36' ' ' ILE . 6.8 tp60 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.579 ' C ' HE22 ' A' ' 31' ' ' GLN . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.628 ' N ' HE22 ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.415 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.5 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.57 ' CB ' ' HD1' ' A' ' 68' ' ' HIS . 1.2 p . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.57 ' HD1' ' CB ' ' A' ' 66' ' ' THR . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.457 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.6 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.654 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 . . . . . 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 ' HZ3' ' A' ' 63' ' ' LYS . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.638 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.821 0.343 . . . . 0.0 110.778 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.607 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.607 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 1.1 t-20 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.531 ' CB ' ' HD1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HD1' ' CB ' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.005 0.431 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 7' ' ' THR . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.617 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.617 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' CG2' HE22 ' A' ' 41' ' ' GLN . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.437 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.3 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 55' ' ' THR . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.41 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.459 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.6 t30 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 36' ' ' ILE . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' NZ ' ' NE2' ' A' ' 62' ' ' GLN . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' NE2' ' NZ ' ' A' ' 48' ' ' LYS . 40.7 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.751 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.414 ' H ' HD13 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.479 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -146.96 157.96 43.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.62 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.62 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.13 -43.2 77.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -99.2 172.16 7.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.1 mtp85 -100.95 143.06 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 mp -114.22 132.47 56.1 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -62.6 -35.99 81.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.454 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 160.62 45.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.956 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.4 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -139.53 133.0 30.23 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 t30 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -55.77 -39.77 71.68 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 68' ' ' HIS . 1.2 p -94.13 176.53 6.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 66' ' ' THR . 17.6 m170 -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD13 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -102.05 138.56 38.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 tp -122.55 137.66 54.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.686 0.279 . . . . 0.0 110.482 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -53.68 -23.68 12.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.688 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.33 -17.52 59.6 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.792 0 CA-C-O 118.091 -1.394 . . . . 0.0 110.936 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -147.48 114.59 6.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.608 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.57 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.2 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.524 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 30.9 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.94 -42.74 76.63 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t -97.87 179.61 4.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.496 ' C ' ' HD1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HD1' ' C ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.458 ' H ' HD11 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -131.56 162.11 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 147.67 42.67 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.664 0.268 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -50.47 133.8 24.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.62 -175.74 44.35 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.999 -1.445 . . . . 0.0 110.861 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -143.84 139.15 29.13 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.528 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.528 ' CD ' HH11 ' A' ' 42' ' ' ARG . 22.0 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.447 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.447 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 61' ' ' ILE . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -56.05 -42.36 76.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.17 177.37 5.99 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -104.19 143.34 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.24 135.37 54.74 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -56.93 -42.17 79.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.519 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.19 -170.08 35.48 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.716 0 CA-C-O 117.886 -1.508 . . . . 0.0 110.844 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.15 159.3 43.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 23' ' ' ILE . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' NH1' ' A' ' 74' ' ' ARG . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.42 -37.87 65.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.85 177.3 6.04 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -103.51 144.75 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 137.96 38.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 0.0 110.37 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 60.7 ttp180 -71.57 -43.16 66.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 -164.08 0.96 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.818 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 35.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' H ' ' CG ' ' A' ' 1' ' ' MET . 18.2 pt20 -144.86 146.64 32.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 10' ' ' GLY . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.597 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.597 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.552 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 8.6 t30 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -55.71 -42.36 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -97.72 175.31 6.23 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.416 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -102.96 143.12 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.4 mt -115.16 139.58 49.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.03 124.72 28.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.503 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.46 -121.31 24.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.936 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -147.36 137.25 23.0 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.8 -43.57 85.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -91.41 176.76 6.44 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' THR . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD13 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 -117.74 151.03 38.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.34 145.85 47.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.246 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -52.79 127.63 23.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.636 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.62 -178.44 51.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 117.991 -1.449 . . . . 0.0 110.845 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' VAL . 12.4 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.89 150.44 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 7' ' ' THR . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.639 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.639 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -55.8 -38.64 70.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -87.79 177.52 6.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 66' ' ' THR . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.463 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -102.35 138.11 39.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tp -123.13 130.5 52.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.399 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -66.85 -45.0 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.76 -150.53 51.33 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.014 -1.436 . . . . 0.0 110.911 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.1 ptt? . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.34 150.98 37.58 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.456 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.456 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' OG1' ' A' ' 7' ' ' THR . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.36 -43.65 83.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.8 OUTLIER -89.62 175.1 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -101.93 140.94 35.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -123.23 130.15 52.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.29 111.59 10.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.704 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.77 -38.62 96.45 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.029 -1.428 . . . . 0.0 110.832 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -145.35 153.44 41.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.688 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.657 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.657 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HZ1' ' CG2' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 61' ' ' ILE . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -55.41 -38.19 68.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER -89.94 177.59 6.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.447 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -99.5 135.7 40.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 tp -122.87 130.68 53.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 110.62 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.82 133.33 49.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.1 51.86 0.24 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.726 0 CA-C-O 117.959 -1.467 . . . . 0.0 110.887 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 30.1 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.5 ' H ' ' CG ' ' A' ' 1' ' ' MET . 20.8 pt20 -144.26 147.25 33.31 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.645 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.645 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.515 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.412 HG21 HD12 ' A' ' 23' ' ' ILE . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.7 t30 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' C ' HE21 ' A' ' 31' ' ' GLN . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.531 HE21 ' C ' ' A' ' 27' ' ' LYS . 48.0 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -53.29 -31.54 44.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 67' ' ' LEU . 12.8 t -100.55 179.19 4.51 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.639 ' H ' ' HG1' ' A' ' 66' ' ' THR . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -103.55 140.29 37.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.87 137.33 54.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -84.24 111.9 19.8 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 110.45 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.32 129.34 24.23 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.016 -1.435 . . . . 0.0 110.923 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 30.5 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.501 ' H ' ' CG ' ' A' ' 1' ' ' MET . 8.9 pt20 -144.95 147.7 33.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.662 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 7' ' ' THR . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.659 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.659 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' HE ' ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.678 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 39.2 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.542 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.03 -40.27 73.21 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O3P' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.04 176.88 6.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' H ' HD13 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -140.71 169.19 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.4 148.17 40.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.42 138.0 56.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' OXT' ' A' ' 76' ' ' GLY . . . 69.12 -128.86 23.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' OXT' ' O ' ' A' ' 75' ' ' GLY . . . . . . . . 0 C--O 1.22 -0.775 0 CA-C-O 117.99 -1.45 . . . . 0.0 110.853 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.7 113.32 6.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.507 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.435 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -56.08 -43.02 77.59 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' H ' ' HG1' ' A' ' 66' ' ' THR . 0.9 OUTLIER -92.61 -179.48 5.19 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -103.64 140.52 37.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -123.37 134.73 53.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.526 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -81.43 122.35 27.4 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.83 0.348 . . . . 0.0 110.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -55.92 26.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.54 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -144.95 147.97 33.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.573 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.73 -34.58 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 66' ' ' THR . 0.9 OUTLIER -96.52 177.64 5.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.65 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -126.39 153.81 44.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.22 158.45 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.773 0.32 . . . . 0.0 110.358 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.78 160.15 29.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.639 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.84 -56.85 2.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.845 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -143.92 145.61 32.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.656 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.649 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.649 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CG2' ' HZ1' ' A' ' 27' ' ' LYS . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' HZ1' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.63 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' CD1' ' NZ ' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.63 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 97.4 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -53.79 -33.83 57.2 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -97.17 177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.404 HD13 ' H ' ' A' ' 70' ' ' VAL . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.404 ' H ' HD13 ' A' ' 69' ' ' LEU . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -101.6 141.0 35.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.95 126.54 51.12 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 mmm-85 -63.81 131.2 47.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.841 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.87 102.49 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 117.941 -1.477 . . . . 0.0 110.94 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -145.31 152.76 40.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.602 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' C ' HD21 ' A' ' 25' ' ' ASN . 0.1 OUTLIER -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 61' ' ' ILE . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.26 -37.86 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.442 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER -93.22 178.04 5.86 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -103.61 148.89 25.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 133.54 50.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.331 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -75.06 -47.75 27.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.22 132.07 1.56 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.911 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.3 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.34 99.37 3.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.565 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 63' ' ' LYS . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 61' ' ' ILE . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -55.97 -38.87 70.98 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -90.97 175.34 7.0 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 66' ' ' THR . 5.2 m-70 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.438 ' H ' HD11 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -107.19 144.98 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 mp -107.41 142.78 36.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.79 0.329 . . . . 0.0 110.277 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -66.46 118.04 9.53 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.625 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.29 -162.11 32.55 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.817 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -147.08 111.19 5.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.692 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 7' ' ' THR . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.645 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.645 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' NZ ' ' CB ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.627 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.627 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -54.59 -37.01 65.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.708 ' HG1' ' NE2' ' A' ' 68' ' ' HIS . 1.1 p -92.53 179.59 5.47 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.708 ' NE2' ' HG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD13 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD13 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -101.27 139.94 36.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -123.58 133.52 53.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.596 0.236 . . . . 0.0 110.4 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -73.59 139.53 45.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.71 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.01 23.0 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.757 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.003 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' VAL . 46.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -144.97 98.87 3.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' A' ' 7' ' ' THR . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' NZ ' ' CD1' ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -55.08 -35.48 64.62 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HG1' ' CE1' ' A' ' 68' ' ' HIS . 1.1 p -90.94 176.48 6.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' CE1' ' HG1' ' A' ' 66' ' ' THR . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.422 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -102.73 143.35 32.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -118.83 137.01 53.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.664 0.268 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -79.15 133.52 36.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.631 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.19 -178.51 46.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.825 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.1 pt20 -147.64 167.08 25.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.625 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.625 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.61 -30.95 45.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.62 176.21 5.92 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 HD13 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' H ' HD13 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -100.21 139.33 36.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.5 mt -119.06 142.32 47.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -75.06 -42.5 56.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.93 140.21 2.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 117.987 -1.451 . . . . 0.0 110.894 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -145.31 153.85 41.71 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 10' ' ' GLY . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.679 ' HE ' ' HE ' ' A' ' 74' ' ' ARG . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -55.92 -39.2 71.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . 0.447 ' O2P' ' CD2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t -93.16 176.74 6.29 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.639 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' N ' ' CD1' ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -119.67 150.48 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.78 153.14 39.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.896 0.379 . . . . 0.0 110.465 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.679 ' HE ' ' HE ' ' A' ' 42' ' ' ARG . 97.4 mtt180 -80.07 165.41 22.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.96 -70.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.774 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.87 -179.996 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -144.51 149.56 36.12 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 34.5 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -56.36 -43.13 78.87 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.548 ' HG1' ' NE2' ' A' ' 68' ' ' HIS . 1.4 p -92.19 179.07 5.67 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' NE2' ' HG1' ' A' ' 66' ' ' THR . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 ' H ' HD11 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -129.5 158.54 38.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.31 154.12 34.02 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -51.14 -52.61 42.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.59 37.0 87.98 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.749 0 CA-C-O 118.007 -1.441 . . . . 0.0 110.905 -179.9 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 17' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.19 149.83 37.05 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.642 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.501 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.501 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 64.6 t30 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' CG2' HE22 ' A' ' 41' ' ' GLN . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.628 HE22 ' N ' ' A' ' 36' ' ' ILE . 6.8 tp60 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.579 ' C ' HE22 ' A' ' 31' ' ' GLN . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.628 ' N ' HE22 ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.5 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -56.05 -41.4 74.98 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.57 ' CB ' ' HD1' ' A' ' 68' ' ' HIS . 1.2 p -92.07 177.4 6.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.57 ' HD1' ' CB ' ' A' ' 66' ' ' THR . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.457 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.457 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.83 142.4 39.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.73 151.38 39.61 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.002 0.429 . . . . 0.0 110.484 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -85.1 125.7 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -140.56 21.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.763 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.795 179.825 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -143.92 147.03 33.41 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.6 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.457 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.88 -42.21 75.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 t -90.22 178.16 6.23 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.459 ' H ' HD13 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 -103.24 140.61 37.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.0 mt -115.9 143.14 45.84 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 110.307 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 33.0 ttm180 -72.1 -30.74 65.39 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.574 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.49 38.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.715 0 CA-C-O 117.922 -1.488 . . . . 0.0 110.811 -179.887 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 17' ' ' VAL . 20.4 ptt? . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -145.55 150.47 36.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.654 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.19 -30.65 50.45 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.82 179.53 5.32 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD13 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.87 143.31 33.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.91 138.96 50.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.884 0.373 . . . . 0.0 110.305 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -50.83 110.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.75 163.65 46.12 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.557 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.5 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -144.42 101.37 3.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.64 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -54.55 -36.47 64.37 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.52 178.88 5.82 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 ' HZ3' ' A' ' 63' ' ' LYS . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' H ' HD11 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -120.24 152.88 37.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mp -102.7 143.49 32.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -68.1 129.92 41.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -48.84 -71.99 0.52 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.755 0 CA-C-O 118.002 -1.443 . . . . 0.0 110.921 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 9.7 tmm? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.609 ' N ' ' SD ' ' A' ' 1' ' ' MET . 11.8 pt20 -145.72 156.01 43.34 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 9' ' ' THR . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' HG1' ' HG1' ' A' ' 7' ' ' THR . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.638 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.12 -42.94 81.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.22 178.25 6.21 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -142.74 171.44 14.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 mt -107.46 144.43 34.41 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -58.05 142.2 47.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.78 81.44 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.742 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.827 -179.885 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -148.89 118.24 6.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 179.679 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.607 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.607 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 1.1 t-20 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -58.09 -46.51 85.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.531 ' CB ' ' HD1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -92.48 177.62 6.07 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.736 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HD1' ' CB ' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.69 32.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 tp -121.19 134.94 55.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -77.49 149.33 35.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.04 54.34 0.33 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.039 -1.423 . . . . 0.0 110.934 179.949 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.575 ' N ' ' O ' ' A' ' 17' ' ' VAL . 33.6 mtm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.05 141.14 32.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 7' ' ' THR . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.617 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.617 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' CG2' HE22 ' A' ' 41' ' ' GLN . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.437 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.3 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HG3' ' H ' ' A' ' 55' ' ' THR . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.41 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' TYR . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.83 -43.44 81.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 178.81 5.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.459 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -103.06 139.53 38.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 tp -122.64 132.41 54.26 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -99.11 88.92 4.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.445 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 60.57 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.033 -1.426 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -145.76 98.13 3.08 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.6 t30 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 36' ' ' ILE . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' NZ ' ' NE2' ' A' ' 62' ' ' GLN . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' NE2' ' NZ ' ' A' ' 48' ' ' LYS . 40.7 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -53.18 -32.8 49.78 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.3 177.09 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.751 ' HD1' ' H ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD13 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.414 ' H ' HD13 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.479 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 -102.32 144.89 30.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.49 131.72 53.99 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -59.04 117.33 4.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.68 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 -13.32 0.09 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.917 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 9' ' ' THR . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 54.8 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' LEU . 15.9 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' H ' HG22 ' A' ' 66' ' ' THR . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 70' ' ' VAL . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' H ' HD12 ' A' ' 69' ' ' LEU . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.1 mtp85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.814 ' C ' HD13 ' A' ' 3' ' ' ILE . 63.1 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.814 HD13 ' C ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.718 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.718 ' N ' HG22 ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.417 ' N ' ' C ' ' A' ' 23' ' ' ILE . 15.3 t-20 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.1 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' HD11 ' A' ' 71' ' ' LEU . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 41' ' ' GLN . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.4 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HA ' HE21 ' A' ' 41' ' ' GLN . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.508 HE21 ' HA ' ' A' ' 38' ' ' PRO . 31.5 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.545 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' CD ' HH11 ' A' ' 42' ' ' ARG . 84.9 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.563 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.563 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 55.5 t-20 -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 69' ' ' LEU . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 3' ' ' ILE . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD2' HG23 ' A' ' 17' ' ' VAL . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.406 ' OD1' ' OD2' ' A' ' 21' ' ' ASP . 6.8 t-20 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 2.3 p-80 -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.614 HD12 ' HZ2' ' A' ' 33' ' ' LYS . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.614 ' HZ2' HD12 ' A' ' 15' ' ' LEU . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.431 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.682 ' H ' HG22 ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.932 0.396 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.0 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 71' ' ' LEU . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.3 pt20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.984 0.421 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.715 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.715 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HZ2' ' HB ' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 2' ' ' GLN . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 121.012 0.434 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' THR . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.735 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 55' ' ' THR . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 2.7 t-20 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 35.6 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 36' ' ' ILE . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 34' ' ' GLU . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.983 0.421 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.722 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.722 ' N ' HG22 ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.782 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.782 ' NE2' HH11 ' A' ' 42' ' ' ARG . 49.6 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' N ' HG23 ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.449 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.691 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 8' ' ' LEU . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 13' ' ' ILE . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.988 0.423 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' THR . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.723 ' N ' HG22 ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' NE ' ' OE1' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' OE1' ' NE ' ' A' ' 42' ' ' ARG . 22.5 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' SER . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' O ' HD21 ' A' ' 8' ' ' LEU . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.689 ' N ' HG22 ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 55' ' ' THR . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 20' ' ' SER . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.575 ' H ' HD13 ' A' ' 69' ' ' LEU . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' O ' HD21 ' A' ' 8' ' ' LEU . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' THR . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 5.2 m-70 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HD12 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.717 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.717 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.8 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' CB ' ' NZ ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' SER . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.1 p . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' NZ ' HD12 ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 20' ' ' SER . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.94 0.4 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 9' ' ' THR . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 55' ' ' THR . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 20' ' ' SER . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LEU . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.678 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.9 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.73 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 69.7 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' H ' HD12 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 121.004 0.431 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.726 ' N ' HG22 ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 4.4 tp-100 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.587 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.523 ' NE2' HD21 ' A' ' 43' ' ' LEU . 35.4 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.523 HD21 ' NE2' ' A' ' 41' ' ' GLN . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 9' ' ' THR . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.714 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.714 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' OE1' ' A' ' 41' ' ' GLN . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.0 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' HG21 ' A' ' 30' ' ' ILE . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 68' ' ' HIS . 2.9 t . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 41' ' ' GLN . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.696 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.696 ' H ' HG22 ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 . . . . . 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' H ' HD12 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.708 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.708 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' HD12 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.68 ' N ' HD13 ' A' ' 69' ' ' LEU . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' THR . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.821 0.343 . . . . 0.0 110.778 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.697 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.697 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' ND1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' ND1' ' OG1' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.692 ' N ' HD13 ' A' ' 69' ' ' LEU . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.005 0.431 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 13' ' ' ILE . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.687 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.687 ' N ' HG22 ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.575 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 51.4 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 69' ' ' LEU . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 55' ' ' THR . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 9.4 t-20 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.521 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -146.96 157.96 43.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 9' ' ' THR . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 54.8 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.13 -43.2 77.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' LEU . 15.9 m -99.2 172.16 7.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' H ' HG22 ' A' ' 66' ' ' THR . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 70' ' ' VAL . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' H ' HD12 ' A' ' 69' ' ' LEU . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 73' ' ' LEU . 35.1 mtp85 -100.95 143.06 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 72' ' ' ARG . 11.1 mp -114.22 132.47 56.1 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -62.6 -35.99 81.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.454 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 160.62 45.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.956 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.4 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.814 ' C ' HD13 ' A' ' 3' ' ' ILE . 63.1 mt-30 -139.53 133.0 30.23 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.814 HD13 ' C ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.718 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.718 ' N ' HG22 ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD2' ' CG2' ' A' ' 17' ' ' VAL . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.417 ' N ' ' C ' ' A' ' 23' ' ' ILE . 15.3 t-20 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.1 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' HD11 ' A' ' 71' ' ' LEU . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -55.77 -39.77 71.68 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -94.13 176.53 6.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 41' ' ' GLN . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -102.05 138.56 38.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 tp -122.55 137.66 54.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.686 0.279 . . . . 0.0 110.482 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -53.68 -23.68 12.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.688 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.33 -17.52 59.6 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.792 0 CA-C-O 118.091 -1.394 . . . . 0.0 110.936 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -147.48 114.59 6.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.608 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.4 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HA ' HE21 ' A' ' 41' ' ' GLN . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.508 HE21 ' HA ' ' A' ' 38' ' ' PRO . 31.5 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.94 -42.74 76.63 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t -97.87 179.61 4.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -131.56 162.11 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 147.67 42.67 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.664 0.268 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -50.47 133.8 24.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.62 -175.74 44.35 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.999 -1.445 . . . . 0.0 110.861 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -143.84 139.15 29.13 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.545 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' CD ' HH11 ' A' ' 42' ' ' ARG . 84.9 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -56.05 -42.36 76.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.17 177.37 5.99 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -104.19 143.34 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.24 135.37 54.74 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -56.93 -42.17 79.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.519 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.19 -170.08 35.48 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.716 0 CA-C-O 117.886 -1.508 . . . . 0.0 110.844 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.15 159.3 43.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 13' ' ' ILE . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.563 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.563 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 55.5 t-20 -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' NH1' ' A' ' 74' ' ' ARG . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.42 -37.87 65.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.85 177.3 6.04 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 69' ' ' LEU . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -103.51 144.75 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.2 137.96 38.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 0.0 110.37 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 60.7 ttp180 -71.57 -43.16 66.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 -164.08 0.96 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.818 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 35.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' H ' ' CG ' ' A' ' 1' ' ' MET . 18.2 pt20 -144.86 146.64 32.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 3' ' ' ILE . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD2' HG23 ' A' ' 17' ' ' VAL . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' OD1' ' OD2' ' A' ' 21' ' ' ASP . 6.8 t-20 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -55.71 -42.36 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -97.72 175.31 6.23 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 2.3 p-80 -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -102.96 143.12 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.4 mt -115.16 139.58 49.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.03 124.72 28.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.503 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.46 -121.31 24.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.936 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -147.36 137.25 23.0 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.614 HD12 ' HZ2' ' A' ' 33' ' ' LYS . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.614 ' HZ2' HD12 ' A' ' 15' ' ' LEU . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.8 -43.57 85.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.41 176.76 6.44 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.431 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 -117.74 151.03 38.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.34 145.85 47.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.246 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -52.79 127.63 23.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.636 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.62 -178.44 51.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 117.991 -1.449 . . . . 0.0 110.845 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.89 150.44 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.682 ' H ' HG22 ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -55.8 -38.64 70.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.404 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.404 ' N ' ' OG ' ' A' ' 65' ' ' SEP . 0.9 OUTLIER -87.79 177.52 6.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -102.35 138.11 39.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tp -123.13 130.5 52.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.399 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -66.85 -45.0 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.76 -150.53 51.33 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.014 -1.436 . . . . 0.0 110.911 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.1 ptt? . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.34 150.98 37.58 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.0 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.36 -43.65 83.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.411 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.411 ' N ' ' OG ' ' A' ' 65' ' ' SEP . 0.8 OUTLIER -89.62 175.1 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 71' ' ' LEU . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -101.93 140.94 35.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -123.23 130.15 52.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.29 111.59 10.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.704 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.77 -38.62 96.45 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.029 -1.428 . . . . 0.0 110.832 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.3 pt20 -145.35 153.44 41.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.715 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.715 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HZ2' ' HB ' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -55.41 -38.19 68.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER -89.94 177.59 6.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 2' ' ' GLN . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -99.5 135.7 40.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 tp -122.87 130.68 53.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 110.62 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.82 133.33 49.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.1 51.86 0.24 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.726 0 CA-C-O 117.959 -1.467 . . . . 0.0 110.887 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' CG ' ' N ' ' A' ' 2' ' ' GLN . 30.1 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' N ' ' CG ' ' A' ' 1' ' ' MET . 20.8 pt20 -144.26 147.25 33.31 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' THR . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 13' ' ' ILE . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.735 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 55' ' ' THR . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 23' ' ' ILE . 2.7 t-20 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' O ' ' N ' ' A' ' 35' ' ' GLY . 35.6 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 36' ' ' ILE . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 34' ' ' GLU . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -53.29 -31.54 44.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -100.55 179.19 4.51 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -103.55 140.29 37.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.87 137.33 54.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -84.24 111.9 19.8 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 110.45 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.32 129.34 24.23 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.016 -1.435 . . . . 0.0 110.923 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 30.5 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' H ' ' CG ' ' A' ' 1' ' ' MET . 8.9 pt20 -144.95 147.7 33.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.662 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.722 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.722 ' N ' HG22 ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.782 HH11 ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.782 ' NE2' HH11 ' A' ' 42' ' ' ARG . 49.6 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' N ' HG23 ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.03 -40.27 73.21 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O3P' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.04 176.88 6.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.449 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -140.71 169.19 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.4 148.17 40.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.42 138.0 56.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' OXT' ' A' ' 76' ' ' GLY . . . 69.12 -128.86 23.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' OXT' ' O ' ' A' ' 75' ' ' GLY . . . . . . . . 0 C--O 1.22 -0.775 0 CA-C-O 117.99 -1.45 . . . . 0.0 110.853 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.7 113.32 6.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.507 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -56.08 -43.02 77.59 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.61 -179.48 5.19 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.691 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 8' ' ' LEU . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -103.64 140.52 37.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -123.37 134.73 53.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.526 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -81.43 122.35 27.4 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.83 0.348 . . . . 0.0 110.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -55.92 26.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -144.95 147.97 33.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 13' ' ' ILE . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.73 -34.58 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.52 177.64 5.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -126.39 153.81 44.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -123.22 158.45 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.773 0.32 . . . . 0.0 110.358 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.78 160.15 29.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.639 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.84 -56.85 2.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.845 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -143.92 145.61 32.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.656 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' THR . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.723 ' N ' HG22 ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' NE ' ' OE1' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' OE1' ' NE ' ' A' ' 42' ' ' ARG . 22.5 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' SER . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -53.79 -33.83 57.2 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -97.17 177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' O ' HD21 ' A' ' 8' ' ' LEU . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -101.6 141.0 35.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -119.95 126.54 51.12 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' N ' HD23 ' A' ' 73' ' ' LEU . 32.5 mmm-85 -63.81 131.2 47.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.841 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.87 102.49 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 117.941 -1.477 . . . . 0.0 110.94 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -145.31 152.76 40.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.689 ' N ' HG22 ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 55' ' ' THR . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 20' ' ' SER . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.26 -37.86 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.442 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER -93.22 178.04 5.86 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.575 ' H ' HD13 ' A' ' 69' ' ' LEU . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' O ' HD21 ' A' ' 8' ' ' LEU . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -103.61 148.89 25.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 133.54 50.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.331 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -75.06 -47.75 27.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.22 132.07 1.56 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.911 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.3 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.34 99.37 3.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HB2' ' HD2' ' A' ' 68' ' ' HIS . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' THR . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -55.97 -38.87 70.98 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.452 ' HG1' ' CG ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -90.97 175.34 7.0 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.453 ' HD2' ' HB2' ' A' ' 4' ' ' PHE . 65.0 m170 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HD12 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' C ' HD12 ' A' ' 73' ' ' LEU . 7.7 mmm180 -107.19 144.98 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 72' ' ' ARG . 10.5 mp -107.41 142.78 36.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.79 0.329 . . . . 0.0 110.277 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -66.46 118.04 9.53 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.625 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.29 -162.11 32.55 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.817 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -147.08 111.19 5.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.692 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.717 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.717 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.8 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' CB ' ' NZ ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' SER . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -54.59 -37.01 65.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.1 p -92.53 179.59 5.47 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -101.27 139.94 36.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -123.58 133.52 53.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.596 0.236 . . . . 0.0 110.4 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -73.59 139.53 45.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.71 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.01 23.0 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.757 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.003 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -144.97 98.87 3.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' NZ ' HD12 ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 20' ' ' SER . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -55.08 -35.48 64.62 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -90.94 176.48 6.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -102.73 143.35 32.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -118.83 137.01 53.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.664 0.268 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -79.15 133.52 36.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.631 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.19 -178.51 46.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.825 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.1 pt20 -147.64 167.08 25.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 9' ' ' THR . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 55' ' ' THR . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 20' ' ' SER . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.61 -30.95 45.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.62 176.21 5.92 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LEU . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -100.21 139.33 36.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.5 mt -119.06 142.32 47.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -75.06 -42.5 56.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.93 140.21 2.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 117.987 -1.451 . . . . 0.0 110.894 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -145.31 153.85 41.71 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.678 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.9 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.722 ' HE ' ' HE ' ' A' ' 74' ' ' ARG . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -55.92 -39.2 71.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SEP . . . . . 0.447 ' O2P' ' CD2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t -93.16 176.74 6.29 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -119.67 150.48 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -122.78 153.14 39.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.896 0.379 . . . . 0.0 110.465 179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.722 ' HE ' ' HE ' ' A' ' 42' ' ' ARG . 97.4 mtt180 -80.07 165.41 22.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.96 -70.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.774 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.87 -179.996 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -144.51 149.56 36.12 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.73 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.552 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 69.7 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -56.36 -43.13 78.87 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -92.19 179.07 5.67 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' H ' HD12 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -129.5 158.54 38.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.31 154.12 34.02 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -51.14 -52.61 42.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.59 37.0 87.98 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.749 0 CA-C-O 118.007 -1.441 . . . . 0.0 110.905 -179.9 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.19 149.83 37.05 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.726 ' N ' HG22 ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 4.4 tp-100 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.587 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.523 ' NE2' HD21 ' A' ' 43' ' ' LEU . 35.4 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.523 HD21 ' NE2' ' A' ' 41' ' ' GLN . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -56.05 -41.4 74.98 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -92.07 177.4 6.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.83 142.4 39.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -120.73 151.38 39.61 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.002 0.429 . . . . 0.0 110.484 179.534 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -85.1 125.7 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -140.56 21.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.763 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.795 179.825 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -143.92 147.03 33.41 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 9' ' ' THR . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.714 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' OE1' ' A' ' 41' ' ' GLN . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.0 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.457 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' HG21 ' A' ' 30' ' ' ILE . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.88 -42.21 75.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 68' ' ' HIS . 2.9 t -90.22 178.16 6.23 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 41' ' ' GLN . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 -103.24 140.61 37.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.0 mt -115.9 143.14 45.84 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 110.307 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 33.0 ttm180 -72.1 -30.74 65.39 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.574 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.49 38.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.715 0 CA-C-O 117.922 -1.488 . . . . 0.0 110.811 -179.887 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -145.55 150.47 36.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.696 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.696 ' H ' HG22 ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.19 -30.65 50.45 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.82 179.53 5.32 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' H ' HD12 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.87 143.31 33.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.0 mp -115.91 138.96 50.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.884 0.373 . . . . 0.0 110.305 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -50.83 110.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.75 163.65 46.12 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.5 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -144.42 101.37 3.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.708 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.708 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -54.55 -36.47 64.37 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.52 178.88 5.82 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' HD12 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -120.24 152.88 37.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 73' ' ' LEU . 11.2 mp -102.7 143.49 32.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -68.1 129.92 41.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -48.84 -71.99 0.52 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.755 0 CA-C-O 118.002 -1.443 . . . . 0.0 110.921 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 9.7 tmm? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.609 ' N ' ' SD ' ' A' ' 1' ' ' MET . 11.8 pt20 -145.72 156.01 43.34 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.12 -42.94 81.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.22 178.25 6.21 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.272 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.68 ' N ' HD13 ' A' ' 69' ' ' LEU . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' THR . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -142.74 171.44 14.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 mt -107.46 144.43 34.41 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -58.05 142.2 47.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.78 81.44 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.742 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.827 -179.885 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -148.89 118.24 6.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 179.679 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.697 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.697 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -58.09 -46.51 85.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' ND1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -92.48 177.62 6.07 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.736 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' ND1' ' OG1' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.692 ' N ' HD13 ' A' ' 69' ' ' LEU . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.69 32.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 tp -121.19 134.94 55.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -77.49 149.33 35.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.04 54.34 0.33 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.039 -1.423 . . . . 0.0 110.934 179.949 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' VAL . 33.6 mtm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.05 141.14 32.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 13' ' ' ILE . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.687 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.687 ' N ' HG22 ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.575 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 51.4 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.83 -43.44 81.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 178.81 5.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 69' ' ' LEU . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -103.06 139.53 38.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 tp -122.64 132.41 54.26 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -99.11 88.92 4.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.445 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 60.57 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.033 -1.426 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -145.76 98.13 3.08 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 55' ' ' THR . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 9.4 t-20 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -53.18 -32.8 49.78 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.3 177.09 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.436 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.521 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 -102.32 144.89 30.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.49 131.72 53.99 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -59.04 117.33 4.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.68 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 -13.32 0.09 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.917 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 9' ' ' THR . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' LEU . 15.9 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' H ' HG22 ' A' ' 66' ' ' THR . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 70' ' ' VAL . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' H ' HD12 ' A' ' 69' ' ' LEU . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.1 mtp85 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.814 ' C ' HD13 ' A' ' 3' ' ' ILE . 63.1 mt-30 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.814 HD13 ' C ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.718 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.718 ' N ' HG22 ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 t30 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' HD11 ' A' ' 71' ' ' LEU . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 41' ' ' GLN . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.784 0.326 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.2 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.532 HE21 HD21 ' A' ' 71' ' ' LEU . 85.2 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.524 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 30.9 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.532 HD21 HE21 ' A' ' 41' ' ' GLN . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.545 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' CD ' HH11 ' A' ' 42' ' ' ARG . 22.0 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.974 0.416 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 69' ' ' LEU . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.037 0.446 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 3' ' ' ILE . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.552 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 8.6 t30 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.614 HD12 ' HZ2' ' A' ' 33' ' ' LYS . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG21 ' NE2' ' A' ' 41' ' ' GLN . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.614 ' HZ2' HD12 ' A' ' 15' ' ' LEU . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' HG21 ' A' ' 30' ' ' ILE . 32.1 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.431 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.682 ' H ' HG22 ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 . . . . . 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.932 0.396 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 71' ' ' LEU . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' LEU . 5.5 pt20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.984 0.421 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.715 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.715 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HZ2' ' HB ' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 2' ' ' GLN . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 . . . . . 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 121.012 0.434 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' THR . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 13' ' ' ILE . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.735 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 55' ' ' THR . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.515 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.7 t30 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' C ' HE21 ' A' ' 31' ' ' GLN . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.564 HE21 ' C ' ' A' ' 27' ' ' LYS . 48.0 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 36' ' ' ILE . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 34' ' ' GLU . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.983 0.421 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.722 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.722 ' N ' HG22 ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.71 ' HE ' ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.71 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 39.2 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.634 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' N ' HG23 ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.449 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.691 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 8' ' ' LEU . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 13' ' ' ILE . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.988 0.423 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' THR . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.723 ' N ' HG22 ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.63 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.63 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 97.4 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' SER . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.624 ' O ' HD21 ' A' ' 8' ' ' LEU . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.689 ' N ' HG22 ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 55' ' ' THR . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 25' ' ' ASN . 0.1 OUTLIER -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 20' ' ' SER . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.575 ' H ' HD13 ' A' ' 69' ' ' LEU . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.54 ' O ' HD21 ' A' ' 8' ' ' LEU . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' THR . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 56' ' ' LEU . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 5.2 m-70 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HD12 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.717 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.717 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' CB ' ' NZ ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' SER . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.1 p . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.541 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' NZ ' HD12 ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 20' ' ' SER . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.94 0.4 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 9' ' ' THR . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 55' ' ' THR . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 20' ' ' SER . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LEU . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.678 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 . . . . . 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 120.964 0.412 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.73 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 34.5 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' H ' HD12 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 . . . . . 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 121.004 0.431 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.726 ' N ' HG22 ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.501 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.501 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 64.6 t30 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.567 HG21 HE22 ' A' ' 41' ' ' GLN . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.645 HE22 ' N ' ' A' ' 36' ' ' ILE . 6.8 tp60 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.609 ' C ' HE22 ' A' ' 31' ' ' GLN . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.645 ' N ' HE22 ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.567 HE22 HG21 ' A' ' 30' ' ' ILE . 12.5 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 9' ' ' THR . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.714 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.714 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' OE1' ' A' ' 41' ' ' GLN . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.6 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' HG21 ' A' ' 30' ' ' ILE . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 68' ' ' HIS . 2.9 t . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 66' ' ' THR . 20.3 m170 -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 41' ' ' GLN . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.696 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.696 ' H ' HG22 ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 . . . . . 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' H ' HD12 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.708 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.708 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' HD12 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.68 ' N ' HD13 ' A' ' 69' ' ' LEU . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' THR . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.821 0.343 . . . . 0.0 110.778 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.697 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.697 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' HE22 ' A' ' 49' ' ' GLN . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 HE22 ' NH2' ' A' ' 42' ' ' ARG . 31.0 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 1.1 t-20 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' ND1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' ND1' ' OG1' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.692 ' N ' HD13 ' A' ' 69' ' ' LEU . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.005 0.431 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 13' ' ' ILE . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.687 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.687 ' N ' HG22 ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.466 ' CG2' HE22 ' A' ' 41' ' ' GLN . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.3 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 69' ' ' LEU . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 41' ' ' GLN . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 55' ' ' THR . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.6 t30 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HZ2' ' NE2' ' A' ' 62' ' ' GLN . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.459 ' NE2' ' HZ2' ' A' ' 48' ' ' LYS . 40.7 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.521 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -146.96 157.96 43.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.952 0.406 . . . . 0.0 110.622 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.2 pt -142.85 146.53 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.812 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -96.01 128.09 42.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.25 114.26 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-O 121.418 0.628 . . . . 0.0 110.151 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -93.26 105.89 17.91 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.817 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.7 p -71.7 169.02 16.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.129 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -79.62 -26.65 41.13 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.308 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' HG22 ' A' ' 9' ' ' THR . 95.2 m -69.83 -8.52 49.03 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.562 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.76 9.17 56.59 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.41 146.47 24.13 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.7 m -121.79 124.43 44.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.9 tt -132.67 131.69 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.082 0.468 . . . . 0.0 109.963 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.0 m -85.12 148.38 26.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.356 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.85 135.22 52.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.633 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.24 126.14 43.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.3 p -152.74 174.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.823 0.82 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.3 mt-10 -104.77 148.48 36.15 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.815 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.63 -25.27 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.352 1.368 . . . . 0.0 111.939 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.0 p -89.05 4.88 46.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 110.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -72.5 149.6 43.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.19 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 p -88.2 170.1 11.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.098 0.475 . . . . 0.0 110.674 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.1 mm -71.93 -51.79 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -44.52 -28.25 0.56 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.197 0.522 . . . . 0.0 109.811 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -72.59 -63.15 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.162 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -48.82 -25.32 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.337 0.589 . . . . 0.0 110.166 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -75.64 -50.35 15.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.22 -31.74 54.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.426 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.82 -62.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.825 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -52.88 -36.97 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.03 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.3 tt0 -62.99 -59.61 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.099 0.476 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.89 -36.24 48.08 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.809 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -80.83 -39.02 27.27 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -108.82 2.85 21.92 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.52 18.23 29.4 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.99 125.29 64.9 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 117.329 0.564 . . . . 0.0 110.748 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -77.19 127.9 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.648 1.565 . . . . 0.0 111.999 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -43.31 -12.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.52 2.146 . . . . 0.0 112.908 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 37' ' ' PRO . 96.1 m-20 -80.84 -43.77 19.47 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.684 0.278 . . . . 0.0 111.438 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -78.5 -16.6 57.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.459 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -114.2 153.58 29.36 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.433 0.635 . . . . 0.0 111.977 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -131.54 133.18 44.79 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -92.28 119.81 32.23 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.455 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -115.45 124.03 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.516 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -139.58 120.68 14.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.602 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.59 34.38 21.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.03 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.76 16.66 72.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.232 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -123.93 127.89 48.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.078 0.439 . . . . 0.0 110.464 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.26 130.43 40.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 50' ' ' LEU . 3.3 mm? -69.09 130.45 42.76 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.086 0.469 . . . . 0.0 110.823 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.2 tt0 -71.63 131.35 43.06 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.29 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -62.34 20.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.713 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.21 18.79 0.19 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.677 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -103.72 171.02 7.59 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 118.145 0.973 . . . . 0.0 111.134 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -106.57 149.93 26.66 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.241 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.6 mp -58.22 -37.58 75.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.509 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -44.97 -41.42 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.647 0.26 . . . . 0.0 111.424 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.57 -36.29 80.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 56' ' ' LEU . 79.6 m-85 -86.18 -5.18 59.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.685 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -81.5 -39.48 24.67 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.708 0.289 . . . . 0.0 110.361 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.65 -51.35 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -69.78 48.05 0.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.224 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -74.86 61.7 1.04 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.603 0.24 . . . . 0.0 111.315 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -56.13 -43.2 77.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.005 0.431 . . . . 0.0 109.871 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' LEU . 15.9 m -99.2 172.16 7.54 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' H ' HG22 ' A' ' 66' ' ' THR . 24.0 mt -78.69 100.83 7.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.627 0.727 . . . . 0.0 110.968 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.5 p80 -142.9 125.14 15.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.873 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 70' ' ' VAL . 30.1 tp -108.62 133.15 53.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.541 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' H ' HD12 ' A' ' 69' ' ' LEU . 62.6 t -103.33 125.99 57.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.18 116.55 28.97 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.935 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 73' ' ' LEU . 35.1 mtp85 -100.95 143.06 31.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.411 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 72' ' ' ARG . 11.1 mp -114.22 132.47 56.1 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -62.6 -35.99 81.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.454 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.09 160.62 45.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.753 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.956 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.4 mtm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.814 ' C ' HD13 ' A' ' 3' ' ' ILE . 63.1 mt-30 -139.53 133.0 30.23 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.944 0.402 . . . . 0.0 110.353 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.814 HD13 ' C ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.2 136.79 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.968 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -94.2 119.8 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.989 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.3 t -107.18 139.48 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.291 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -116.97 105.94 12.87 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.261 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -71.98 167.33 20.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.411 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.42 -25.06 62.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.976 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 p -75.34 -5.78 46.51 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.508 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.77 16.91 55.75 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -91.21 147.16 23.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.1 m -119.17 121.75 40.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.577 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.5 tt -132.41 128.22 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 109.891 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.91 148.9 25.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.384 0.612 . . . . 0.0 111.283 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.21 135.58 54.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.654 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -101.34 125.31 47.96 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.718 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.6 p -154.43 176.94 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.564 0.697 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.718 ' N ' HG22 ' A' ' 17' ' ' VAL . 63.6 mm-40 -96.05 151.36 38.21 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.394 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.46 -27.28 23.33 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.34 1.36 . . . . 0.0 111.876 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.7 m -87.17 6.1 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.578 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 16.6 t0 -73.31 148.25 43.71 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -86.41 171.01 11.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.095 0.474 . . . . 0.0 110.691 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -69.95 -49.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.428 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -44.42 -24.79 0.2 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 109.831 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 2.0 t30 -76.63 -62.65 1.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.356 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.3 t -47.44 -26.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.309 0.576 . . . . 0.0 110.312 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -71.83 -50.2 31.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.59 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -32.78 44.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.796 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -69.28 -64.53 0.86 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.344 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -49.93 -37.46 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -63.85 -58.93 5.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.187 0.517 . . . . 0.0 110.494 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -52.81 -39.95 62.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.97 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -79.68 -43.59 22.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -103.1 0.82 32.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.5 24.06 45.04 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.896 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 111.45 54.54 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 117.398 0.599 . . . . 0.0 110.683 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.83 156.89 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.948 1.765 . . . . 0.0 111.822 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.64 -46.79 1.64 Allowed 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.573 2.182 . . . . 0.0 112.785 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -65.46 -22.32 66.74 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.885 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -80.37 -22.98 40.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.644 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' HB2' HD11 ' A' ' 71' ' ' LEU . 14.1 pt20 -112.11 152.26 28.48 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.382 0.61 . . . . 0.0 111.882 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -132.1 132.06 42.94 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -94.17 117.27 29.87 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.198 0.523 . . . . 0.0 111.426 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.32 122.37 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.7 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -140.2 122.79 16.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.571 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.66 34.65 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.84 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.26 18.41 67.23 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.385 -0.436 . . . . 0.0 112.022 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -123.38 126.82 47.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.069 0.435 . . . . 0.0 110.461 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -75.04 130.8 39.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.116 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -68.84 135.92 51.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.067 0.46 . . . . 0.0 110.802 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.2 tt0 -69.8 136.08 50.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.219 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.36 14.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.82 26.29 0.22 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.753 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -103.07 170.58 7.88 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 118.06 0.93 . . . . 0.0 111.173 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.6 p -105.36 150.93 24.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.123 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.3 mp -56.89 -37.36 71.29 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.9 -39.01 17.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.602 0.239 . . . . 0.0 111.525 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.69 -38.01 88.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 56' ' ' LEU . 67.5 m-85 -86.38 -2.28 58.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.466 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -84.14 -34.5 24.04 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 122.204 -0.31 . . . . 0.0 110.313 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 63' ' ' LYS . 84.3 mt -66.06 -54.0 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -68.77 47.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.945 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 61' ' ' ILE . 34.5 ttpt -77.5 59.09 1.85 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -55.77 -39.77 71.68 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -94.13 176.53 6.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.4 mt -79.53 43.34 0.56 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 0.0 110.915 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -83.61 119.48 24.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.94 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.2 tp -110.24 135.0 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.528 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.0 t -103.69 123.89 57.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 41' ' ' GLN . 26.6 tp -94.72 122.0 36.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.072 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 mtm180 -102.05 138.56 38.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.264 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 tp -122.55 137.66 54.82 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.686 0.279 . . . . 0.0 110.482 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -53.68 -23.68 12.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.688 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.33 -17.52 59.6 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.792 0 CA-C-O 118.091 -1.394 . . . . 0.0 110.936 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -147.48 114.59 6.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.608 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.2 pt -100.1 147.99 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -95.56 130.07 42.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.16 117.22 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 121.399 0.618 . . . . 0.0 110.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -93.63 108.61 20.31 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.827 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -74.39 166.38 23.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.159 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -73.63 -26.41 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 122.09 -0.381 . . . . 0.0 111.263 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.8 p -70.44 -5.33 27.76 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.425 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.21 10.26 66.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -92.02 139.31 30.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -112.76 125.75 54.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.731 0.3 . . . . 0.0 110.628 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.8 tt -132.34 131.64 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.4 m -82.47 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.436 0.636 . . . . 0.0 111.173 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.45 130.53 54.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.609 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -94.21 122.87 37.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.4 p -150.17 168.17 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.64 0.733 . . . . 0.0 110.886 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mt-10 -97.69 139.94 21.67 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.32 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' SER . 37.6 Cg_endo -64.0 -8.18 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.405 1.403 . . . . 0.0 112.289 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -98.56 -26.67 14.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.317 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -50.33 149.56 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 0.0 110.264 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.6 p -82.84 175.93 9.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -71.25 -40.17 73.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.52 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE1' ' OD1' ' A' ' 52' ' ' ASP . 14.0 mm-40 -51.15 -24.19 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.9 -62.5 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.491 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -47.73 -28.27 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.461 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.02 -53.11 10.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.427 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.44 -33.25 43.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.694 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -67.54 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.604 -0.438 . . . . 0.0 109.91 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.84 -39.82 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.2 tt0 -57.1 -61.36 2.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.84 -37.43 43.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.922 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -80.94 -35.68 31.99 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -108.34 1.49 21.89 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 17.54 27.73 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.686 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -95.4 132.04 28.5 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 117.42 0.61 . . . . 0.0 110.692 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.85 120.96 7.21 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.618 1.545 . . . . 0.0 111.623 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -44.3 -21.01 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.711 2.274 . . . . 0.0 113.071 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.6 -38.42 80.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 111.203 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -85.25 -7.84 58.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.762 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.532 HE21 HD21 ' A' ' 71' ' ' LEU . 85.2 mt-30 -101.06 144.02 30.48 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.21 0.529 . . . . 0.0 111.929 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.524 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -124.14 123.77 41.02 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.64 117.96 30.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.192 0.52 . . . . 0.0 111.274 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.01 121.59 64.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.706 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -141.4 125.56 17.39 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.469 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.11 34.45 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.96 17.53 67.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.212 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -125.64 131.7 52.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.077 0.439 . . . . 0.0 110.778 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 30.9 mt-30 -75.35 129.64 37.7 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.961 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -67.08 134.11 51.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.092 0.472 . . . . 0.0 110.852 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 12.9 tt0 -72.26 131.1 42.27 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.275 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE1' ' A' ' 24' ' ' GLU . 22.0 t70 -62.56 18.82 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.87 19.54 0.29 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 119.617 -1.278 . . . . 0.0 113.738 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -105.01 173.55 6.26 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.128 0.964 . . . . 0.0 111.012 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -106.26 149.88 26.46 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.303 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.5 mp -57.35 -38.56 74.32 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.33 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 19' ' ' PRO . 15.0 t -45.72 -38.19 6.67 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.649 0.261 . . . . 0.0 111.252 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -62.69 -37.37 86.19 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 56' ' ' LEU . 78.6 m-85 -85.02 -4.81 59.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.395 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 -40.18 23.34 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.395 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.93 -50.62 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -69.97 47.55 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.056 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -74.59 60.88 0.92 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.94 -42.74 76.63 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.6 t -97.87 179.61 4.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.46 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 24.3 mt -80.61 96.42 6.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.239 0.542 . . . . 0.0 111.229 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' ND1' ' O ' ' A' ' 67' ' ' LEU . 9.8 m80 -143.24 123.56 13.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.693 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.7 tp -111.3 137.37 49.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.485 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.07 123.06 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.532 HD21 HE21 ' A' ' 41' ' ' GLN . 29.3 tp -95.41 125.63 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.262 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -131.56 162.11 31.07 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 147.67 42.67 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.664 0.268 . . . . 0.0 110.278 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -50.47 133.8 24.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.729 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.62 -175.74 44.35 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.79 0 CA-C-O 117.999 -1.445 . . . . 0.0 110.861 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 mtm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -143.84 139.15 29.13 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.142 0.496 . . . . 0.0 110.719 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -138.63 146.05 27.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.22 124.0 40.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.707 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.74 113.9 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.453 0.644 . . . . 0.0 110.027 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp -92.7 107.7 19.42 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.98 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -74.37 167.94 20.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.984 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -75.7 -28.44 58.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.485 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.2 p -69.93 -1.16 8.82 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.34 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.95 9.1 74.69 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -88.85 141.32 28.6 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 m -121.42 124.54 44.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.713 0.292 . . . . 0.0 110.495 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 pt -136.64 134.29 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.186 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -82.87 149.18 27.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.615 0.721 . . . . 0.0 111.142 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.24 137.52 54.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.761 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -100.93 125.03 47.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.8 p -148.32 165.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.698 0.761 . . . . 0.0 110.926 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.8 mm-40 -98.14 145.02 29.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.77 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.98 -26.33 78.58 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.42 1.414 . . . . 0.0 112.054 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.5 m -89.99 7.95 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 14.9 t0 -76.48 148.74 37.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.213 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -86.84 166.39 15.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.224 0.535 . . . . 0.0 110.75 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.7 mm -68.72 -45.57 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.532 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.5 mm-40 -49.51 -23.37 1.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.256 0.551 . . . . 0.0 109.632 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' CB ' ' OD1' ' A' ' 21' ' ' ASP . 12.4 t-20 -76.97 -63.08 1.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -46.57 -28.59 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.343 0.592 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -71.95 -48.98 41.33 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.818 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.43 -32.9 51.87 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.524 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -67.98 -63.98 0.95 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.946 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.94 -40.95 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 35' ' ' GLY . 1.0 OUTLIER -58.38 -58.36 8.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.476 . . . . 0.0 110.231 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -52.62 -37.17 57.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.575 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -77.19 -41.73 40.39 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.78 6.08 25.24 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.0 18.38 26.35 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.794 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -95.53 112.65 59.64 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 117.473 0.636 . . . . 0.0 110.629 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.18 155.01 1.14 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.837 1.691 . . . . 0.0 111.837 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.6 -31.2 11.16 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.526 2.151 . . . . 0.0 112.832 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.48 -31.35 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.336 . . . . 0.0 111.14 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -81.9 -14.08 56.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.639 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -102.95 144.67 30.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.163 0.506 . . . . 0.0 111.879 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.545 HH11 ' CD ' ' A' ' 49' ' ' GLN . 22.6 mmm180 -126.62 123.68 38.17 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.4 mt -94.03 121.49 35.56 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.083 0.468 . . . . 0.0 111.633 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.93 124.36 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.556 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -143.56 124.43 14.28 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.539 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.01 32.59 21.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.973 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.82 18.36 70.35 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.421 -0.418 . . . . 0.0 112.234 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -124.74 129.43 50.46 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.053 0.426 . . . . 0.0 110.554 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' CD ' HH11 ' A' ' 42' ' ' ARG . 22.0 mt-30 -75.69 131.73 40.08 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.4 mp -71.2 133.46 46.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.054 0.454 . . . . 0.0 110.806 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.6 tt0 -75.19 134.71 41.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.441 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -63.41 26.93 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.43 16.74 0.12 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 119.424 -1.369 . . . . 0.0 113.675 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HG3' ' H ' ' A' ' 55' ' ' THR . 5.2 tpt180 -103.62 171.56 7.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.144 0.972 . . . . 0.0 111.204 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 71.9 p -106.52 150.32 26.24 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.234 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.8 mp -57.62 -39.08 76.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.408 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.5 p -45.66 -39.42 7.83 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.832 0.349 . . . . 0.0 111.346 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.07 -35.71 77.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.9 m-85 -86.81 -6.33 58.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.515 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -78.03 -38.09 45.46 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.75 -51.68 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.07 47.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.137 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -74.98 61.2 1.03 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.638 0.256 . . . . 0.0 111.594 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -56.05 -42.36 76.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.104 0.478 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.17 177.37 5.99 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.1 mt -79.06 45.49 0.63 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.237 0.541 . . . . 0.0 111.012 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -87.09 120.63 28.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.989 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.2 tp -111.68 136.19 51.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.501 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HD12 ' A' ' 69' ' ' LEU . 76.5 t -104.11 125.48 58.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.62 116.94 29.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -104.19 143.34 33.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.468 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -122.24 135.37 54.74 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.748 0.309 . . . . 0.0 110.411 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -56.93 -42.17 79.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.519 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.19 -170.08 35.48 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.716 0 CA-C-O 117.886 -1.508 . . . . 0.0 110.844 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -147.15 159.3 43.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.32 145.78 23.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.832 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -96.3 130.21 43.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.474 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.84 138.59 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.167 0.508 . . . . 0.0 109.961 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -115.12 105.4 12.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.501 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.1 p -74.01 167.21 21.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.269 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -72.42 -23.24 61.06 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.157 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -77.19 3.26 13.16 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.426 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.88 15.25 80.99 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.06 132.02 36.28 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.8 m -106.88 121.45 44.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.4 tt -130.77 129.78 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -83.96 147.51 27.43 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.035 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.68 139.9 52.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.609 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -101.57 125.34 48.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.5 p -147.16 165.27 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.766 0.793 . . . . 0.0 110.931 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.8 mt-10 -96.9 129.33 32.83 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.594 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -48.88 -28.37 13.06 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.299 1.333 . . . . 0.0 112.293 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.8 t -86.16 2.4 47.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' OD1' ' A' ' 25' ' ' ASN . 28.5 t0 -72.49 150.43 43.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.28 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.8 p -86.61 171.94 10.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.616 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -73.6 -47.06 46.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.678 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -49.81 -23.77 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.207 0.527 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -76.78 -62.62 1.58 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.524 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.4 t -43.45 -29.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.444 0.64 . . . . 0.0 110.483 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -73.46 -49.26 27.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.574 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -53.12 -36.7 61.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.629 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -64.26 -64.48 0.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.764 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.7 mt -50.92 -40.57 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' GLY . 15.6 tt0 -56.98 -61.18 2.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.046 0.45 . . . . 0.0 110.365 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -51.12 -37.81 48.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.91 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -41.18 43.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.11 8.37 23.84 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.64 17.01 18.77 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.034 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 mt -90.64 134.15 31.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.321 0.56 . . . . 0.0 110.365 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.18 150.04 32.76 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.895 1.73 . . . . 0.0 111.742 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.6 -21.36 52.51 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.721 2.281 . . . . 0.0 112.838 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -72.31 -27.59 62.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.885 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' NH1' ' A' ' 74' ' ' ARG . 14.9 mm100 -88.52 -18.25 28.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.752 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -103.84 144.66 31.2 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.319 0.58 . . . . 0.0 112.008 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.6 mmm-85 -131.28 129.3 41.36 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mt -94.21 116.74 29.18 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.519 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mm -110.19 122.22 64.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.597 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -139.88 124.26 18.01 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.41 36.89 21.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.06 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.89 18.81 66.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.279 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.22 126.88 46.85 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.018 0.409 . . . . 0.0 110.469 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -76.46 132.41 39.61 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.065 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -70.29 134.8 48.32 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.919 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 53' ' ' GLY . 18.5 tt0 -73.01 131.69 42.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.361 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -62.17 17.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -154.04 17.17 0.62 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.717 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -107.24 175.15 5.59 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.93 0.865 . . . . 0.0 111.207 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.7 p -108.43 152.4 24.74 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.287 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.9 mp -57.9 -36.89 73.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.268 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.0 t -46.37 -40.46 12.02 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.775 0.321 . . . . 0.0 111.477 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.44 -36.92 83.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.4 m-85 -85.49 -4.68 59.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.366 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -80.93 -37.33 29.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.2 mt -63.17 -53.88 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -70.17 45.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.032 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -76.2 59.54 1.38 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.533 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -54.42 -37.87 65.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.85 177.3 6.04 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.8 mt -79.93 43.8 0.62 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.302 0.573 . . . . 0.0 110.756 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.84 120.77 25.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.003 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.54 130.51 55.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.388 -178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.69 ' N ' HD13 ' A' ' 69' ' ' LEU . 59.6 t -104.11 125.61 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.53 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 -103.51 144.75 31.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.747 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -101.2 137.96 38.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 0.0 110.37 179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' NH1' ' OE1' ' A' ' 40' ' ' GLN . 60.7 ttp180 -71.57 -43.16 66.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.578 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.1 -164.08 0.96 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.818 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 35.0 ttp . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' H ' ' CG ' ' A' ' 1' ' ' MET . 18.2 pt20 -144.86 146.64 32.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 3' ' ' ILE . 33.6 pt -143.07 147.65 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.961 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.01 128.13 42.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.559 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -109.38 113.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.386 0.612 . . . . 0.0 110.163 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 3.8 ttpm? -92.05 105.34 17.6 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.964 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.5 p -73.79 171.23 13.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.104 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.6 tp -77.25 -32.57 55.76 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.082 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.7 p -69.1 0.64 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.521 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.94 12.42 77.05 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -90.41 127.94 36.34 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -104.1 123.36 47.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.7 tt -132.71 130.03 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -83.34 146.89 28.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.346 0.593 . . . . 0.0 111.115 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.32 132.46 54.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.787 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.33 123.97 40.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.692 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.4 p -152.61 174.4 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-O 121.815 0.817 . . . . 0.0 110.969 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.692 ' N ' HG22 ' A' ' 17' ' ' VAL . 52.5 mt-10 -104.96 150.24 38.49 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.773 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.71 -40.99 20.22 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.175 1.25 . . . . 0.0 112.091 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.3 m -73.76 4.6 4.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.678 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.552 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 33.4 t0 -72.06 149.33 44.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.067 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -87.41 164.9 15.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.315 0.578 . . . . 0.0 110.867 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -67.68 -49.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.601 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.84 -23.78 0.83 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.168 0.508 . . . . 0.0 109.683 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 8.6 t30 -74.87 -61.7 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.229 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.5 t -47.6 -27.05 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.256 0.55 . . . . 0.0 110.239 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -72.31 -50.25 28.37 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.634 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.83 -34.74 60.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.647 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -66.12 -64.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.9 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -52.17 -41.46 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' GLY . 65.2 tt0 -59.28 -60.77 3.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.014 0.435 . . . . 0.0 110.489 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -49.4 -35.38 18.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.85 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -80.86 -43.45 19.92 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 5.43 28.68 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.67 25.61 43.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.884 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 16.3 mt -99.16 109.45 54.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 117.628 0.714 . . . . 0.0 110.736 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.68 146.83 14.64 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.879 1.719 . . . . 0.0 112.05 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.79 -24.24 47.21 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.529 2.153 . . . . 0.0 112.869 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.98 -29.26 65.18 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.76 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -84.51 -15.11 47.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.542 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 29.6 mt-30 -106.76 148.85 27.96 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 111.913 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -128.9 126.42 39.66 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.57 114.16 25.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.246 0.546 . . . . 0.0 111.56 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -109.85 120.0 60.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -139.86 120.71 14.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.47 35.33 24.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.46 17.15 68.32 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.218 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -123.94 126.97 47.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.052 0.426 . . . . 0.0 110.473 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -75.81 131.42 39.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.195 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.2 mp -71.71 134.32 46.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.11 0.481 . . . . 0.0 110.696 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 8.8 tt0 -72.88 133.69 44.51 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.394 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -62.84 31.56 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.66 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.39 18.5 0.07 OUTLIER Glycine 0 CA--C 1.532 1.115 0 C-N-CA 119.363 -1.399 . . . . 0.0 113.56 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.514 ' NH2' ' OD2' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -104.94 172.56 6.72 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.102 0.951 . . . . 0.0 111.136 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -105.61 150.34 25.5 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.359 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.9 mp -59.3 -37.7 78.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.31 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 m -45.53 -40.37 8.52 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 120.694 0.283 . . . . 0.0 111.247 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD2' ' NH2' ' A' ' 54' ' ' ARG . 51.0 t0 -61.81 -36.61 81.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.0 m-85 -86.03 -5.89 59.13 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.484 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -80.04 -39.94 28.8 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.354 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.2 -50.31 80.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -69.14 48.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.304 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -75.6 59.94 1.19 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.675 0.274 . . . . 0.0 111.591 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -55.71 -42.36 75.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.098 0.475 . . . . 0.0 109.918 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -97.72 175.31 6.23 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -81.19 101.04 9.43 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.252 0.548 . . . . 0.0 111.465 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -143.11 125.16 15.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.993 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 70' ' ' VAL . 25.2 tp -108.6 132.65 53.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.412 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' N ' HD12 ' A' ' 69' ' ' LEU . 45.3 t -102.69 123.94 56.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.59 115.66 28.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -102.96 143.12 32.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.217 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.4 mt -115.16 139.58 49.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.902 0.382 . . . . 0.0 110.472 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -77.03 124.72 28.2 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.503 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.46 -121.31 24.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.936 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -147.36 137.25 23.0 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.459 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -100.11 147.2 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.081 0.467 . . . . 0.0 110.723 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -96.24 131.44 42.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.67 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.6 t -113.42 139.54 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 109.875 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -116.72 107.14 14.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.295 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.2 p -73.9 165.8 24.48 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.116 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.14 -29.14 63.76 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.267 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.3 p -70.37 -3.11 15.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.427 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.6 72.89 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -92.92 112.61 24.63 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.3 m -93.26 127.02 38.67 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 pt -135.43 136.52 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 110.064 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -81.66 145.19 30.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.376 0.607 . . . . 0.0 111.339 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.614 HD12 ' HZ2' ' A' ' 33' ' ' LYS . 1.1 tp -120.51 130.39 54.23 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.652 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -95.74 122.78 38.88 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.6 p -150.65 167.18 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.901 0.858 . . . . 0.0 110.972 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 50.8 mt-10 -94.54 136.82 22.86 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.128 -1.396 . . . . 0.0 109.334 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.11 -6.21 10.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.55 1.5 . . . . 0.0 112.242 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.9 p -97.3 -29.36 13.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.41 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -51.2 146.89 6.07 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.13 0.491 . . . . 0.0 110.769 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -81.52 179.82 7.68 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.425 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -72.66 -46.4 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.523 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -45.08 -25.45 0.34 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.266 0.555 . . . . 0.0 109.872 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.3 t30 -76.58 -61.01 2.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.238 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.1 t -47.45 -27.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.363 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -71.6 -50.15 33.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.65 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.82 -34.37 59.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.593 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -66.28 -66.24 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.029 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG21 ' NE2' ' A' ' 41' ' ' GLN . 61.6 mt -49.73 -37.84 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 35' ' ' GLY . 63.3 tt0 -58.09 -61.05 2.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.541 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -51.14 -37.08 44.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.924 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.614 ' HZ2' HD12 ' A' ' 15' ' ' LEU . 88.9 mttt -75.34 -48.95 20.71 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 59.0 mm-40 -108.31 10.28 27.68 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.84 31.42 58.21 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.312 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 34' ' ' GLU . 5.1 mm -99.3 107.8 46.73 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 117.417 0.609 . . . . 0.0 110.408 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.65 154.68 1.74 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.781 1.654 . . . . 0.0 112.168 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -64.23 -41.8 20.26 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.416 2.078 . . . . 0.0 112.611 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.07 -28.62 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.954 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -84.01 -21.06 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.51 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' NE2' HG21 ' A' ' 30' ' ' ILE . 32.1 mt-30 -86.96 134.07 33.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 112.021 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -123.28 114.13 19.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.68 114.45 26.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.249 0.547 . . . . 0.0 111.365 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.39 123.97 67.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.841 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -140.4 116.31 10.36 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.613 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.39 41.09 23.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.98 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.08 18.35 60.11 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.126 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -123.88 126.94 47.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.014 0.407 . . . . 0.0 110.467 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -78.24 129.99 35.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.5 mp -69.69 138.8 53.24 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.943 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.3 tt0 -72.84 131.41 42.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.182 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -63.05 21.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.65 17.99 0.29 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 119.551 -1.309 . . . . 0.0 113.776 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -104.8 173.22 6.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.048 0.924 . . . . 0.0 110.984 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.1 p -107.95 151.24 26.07 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.232 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.7 mp -56.33 -37.69 70.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -46.02 -39.84 9.72 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.587 0.232 . . . . 0.0 111.198 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.73 -37.88 85.86 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.0 m-85 -86.63 -4.14 59.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.501 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -81.74 -37.37 27.36 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.349 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.9 mt -64.45 -50.53 75.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -70.68 46.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.993 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.7 ttmt -73.74 61.1 0.73 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -57.8 -43.57 85.76 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.41 176.76 6.44 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.8 mt -79.89 40.63 0.47 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.207 0.527 . . . . 0.0 110.681 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -81.26 122.69 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 108.811 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.6 tp -113.84 136.49 52.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.552 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.431 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.2 t -104.1 124.52 58.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.896 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -91.86 121.22 33.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.696 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.4 mmm-85 -117.74 151.03 38.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.34 145.85 47.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.246 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -52.79 127.63 23.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.636 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.62 -178.44 51.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 117.991 -1.449 . . . . 0.0 110.845 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.89 150.44 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 110.967 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.6 pt -141.68 145.93 23.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.112 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -98.46 129.79 45.06 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.489 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.57 114.96 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.485 0.659 . . . . 0.0 110.323 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -91.05 108.93 20.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.589 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.7 p -71.19 161.54 30.93 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.31 -23.08 60.22 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.321 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.8 p -74.33 -10.85 59.99 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.456 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.72 8.51 54.32 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -92.6 130.95 38.09 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -106.21 125.27 50.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.672 0.272 . . . . 0.0 110.696 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.0 tt -131.07 129.93 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 109.755 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -83.26 144.59 29.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.339 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.71 135.19 53.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.715 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -100.8 125.99 47.35 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.6 p -155.39 175.95 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.937 0.875 . . . . 0.0 110.907 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.682 ' H ' HG22 ' A' ' 17' ' ' VAL . 77.9 mt-10 -100.53 146.51 32.16 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 113.82 -1.537 . . . . 0.0 109.586 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.01 -18.87 46.2 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.594 1.529 . . . . 0.0 111.802 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 t -92.56 -0.71 57.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.36 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -67.72 151.68 46.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.085 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 p -84.74 170.91 12.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.8 mm -72.03 -52.42 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.743 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.97 -23.93 0.36 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.213 0.53 . . . . 0.0 109.703 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' ILE . 14.6 t-20 -73.12 -64.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.277 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -45.64 -27.56 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.4 0.619 . . . . 0.0 110.491 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -72.69 -47.33 48.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.716 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.95 47.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.655 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -66.01 -64.05 0.95 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.784 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.25 -36.85 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -61.0 -62.1 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.041 0.448 . . . . 0.0 110.784 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -52.02 -39.41 59.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.069 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -79.08 -41.86 27.7 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -103.63 4.35 35.47 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.06 17.75 24.32 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.898 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mt -93.93 132.55 29.37 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 117.57 0.685 . . . . 0.0 110.531 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.05 123.48 8.39 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.632 1.555 . . . . 0.0 111.591 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.84 -20.31 0.25 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.541 2.16 . . . . 0.0 113.242 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.64 -40.45 88.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.084 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -84.23 -8.63 58.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.413 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -103.98 143.73 32.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.319 0.581 . . . . 0.0 111.973 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.614 ' NH1' ' NE2' ' A' ' 49' ' ' GLN . 16.5 mmm180 -132.53 133.01 43.21 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -95.99 115.74 27.89 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.099 0.476 . . . . 0.0 111.624 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.51 123.91 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.737 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -137.05 115.21 11.62 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.957 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.94 34.69 22.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.2 14.83 78.88 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.407 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -116.63 123.35 47.08 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.308 0.554 . . . . 0.0 110.424 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' NE2' ' NH1' ' A' ' 42' ' ' ARG . 27.0 mt-30 -77.59 129.19 35.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 50' ' ' LEU . 6.8 mp -70.39 136.93 50.05 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.95 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 53' ' ' GLY . 53.7 tt0 -72.9 133.29 44.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.414 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 0.6 OUTLIER -62.95 17.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.592 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.37 18.7 0.38 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.544 -1.312 . . . . 0.0 113.645 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -105.25 174.34 5.92 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.975 0.887 . . . . 0.0 111.043 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -107.76 151.37 25.8 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.392 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' A' ' 56' ' ' LEU . 9.2 mp -57.59 -36.84 72.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.375 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.5 p -44.89 -41.32 7.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.535 0.207 . . . . 0.0 111.503 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.79 -38.9 92.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 56' ' ' LEU . 59.7 m-85 -86.81 -1.5 57.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.528 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.7 t30 -84.18 -42.63 15.78 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.392 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 62' ' ' GLN . 13.1 tt -59.05 -45.9 92.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 26.2 mm100 -70.62 45.68 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.01 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 47.4 pttt -77.42 58.97 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.614 0.245 . . . . 0.0 111.651 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -55.8 -38.64 70.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.114 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.404 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.404 ' N ' ' OG ' ' A' ' 65' ' ' SEP . 0.9 OUTLIER -87.79 177.52 6.98 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -81.17 37.77 0.45 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.699 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -81.93 125.45 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.154 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.8 tp -113.56 140.09 48.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.772 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.87 122.73 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -93.79 121.77 35.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.826 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 -102.35 138.11 39.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.371 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tp -123.13 130.5 52.85 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.399 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -66.85 -45.0 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.756 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.76 -150.53 51.33 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 118.014 -1.436 . . . . 0.0 110.911 -179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.1 ptt? . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.34 150.98 37.58 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.724 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.9 pt -142.7 146.76 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.876 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.66 127.29 42.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.341 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.13 113.77 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 110.349 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -89.62 106.88 18.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 p -74.03 167.69 21.02 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.0 mt -77.82 -26.25 49.38 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.077 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.5 p -71.53 -4.45 26.9 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.537 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.01 9.37 67.81 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -95.05 121.55 36.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -100.59 129.19 46.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.508 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 pt -136.6 134.8 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.99 0.424 . . . . 0.0 110.03 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.0 m -82.66 147.51 28.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.399 0.619 . . . . 0.0 111.258 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.34 134.03 54.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.622 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 37.6 mp0 -98.95 123.75 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.4 p -148.03 165.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.801 0.81 . . . . 0.0 110.824 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 36.7 mt-10 -96.0 128.4 37.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.6 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -48.27 -29.58 13.28 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.341 1.361 . . . . 0.0 112.144 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.5 m -83.97 3.77 32.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.932 0.396 . . . . 0.0 110.764 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -75.34 148.48 39.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.579 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -85.01 171.32 12.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 110.587 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.9 -48.9 48.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.47 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.6 mm-40 -45.09 -23.59 0.17 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.239 0.542 . . . . 0.0 109.663 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' N ' ' C ' ' A' ' 23' ' ' ILE . 29.9 t-20 -75.45 -61.16 2.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.129 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.12 -24.97 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.283 0.563 . . . . 0.0 110.307 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -74.68 -50.58 17.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.406 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -33.33 52.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.55 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -68.18 -63.34 1.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.96 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.0 mt -51.21 -40.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -57.54 -59.92 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.159 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -49.55 -36.52 23.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.666 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -77.04 -43.97 32.51 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -111.05 8.82 22.0 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.23 16.8 21.58 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.73 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.5 mt -90.14 124.04 64.3 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 117.287 0.544 . . . . 0.0 110.701 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.56 158.19 47.88 Favored 'Trans proline' 0 N--CA 1.5 1.908 0 C-N-CA 121.95 1.767 . . . . 0.0 111.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -63.39 -17.36 59.7 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.641 2.227 . . . . 0.0 112.873 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -30.17 30.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.835 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -84.69 -24.03 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.548 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -111.69 151.2 29.16 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.22 0.533 . . . . 0.0 111.928 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' CD ' ' NE2' ' A' ' 49' ' ' GLN . 14.8 mmt85 -132.03 134.58 45.7 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.17 116.28 28.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.128 0.49 . . . . 0.0 111.431 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.9 mm -108.87 120.64 60.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.736 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -139.2 120.63 15.0 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.563 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.98 37.51 24.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.049 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.4 17.49 66.45 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.25 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -122.98 125.67 45.71 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.103 0.452 . . . . 0.0 110.547 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' NE2' ' CD ' ' A' ' 42' ' ' ARG . 42.3 tt0 -76.38 130.65 38.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.165 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.6 mp -70.26 136.83 50.25 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.805 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.2 tt0 -72.87 131.51 42.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.4 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -62.82 19.35 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -156.95 16.98 0.38 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.744 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -103.88 172.64 6.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.049 0.925 . . . . 0.0 111.192 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -104.53 150.57 24.5 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.209 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.4 mp -57.69 -38.87 75.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.247 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -46.44 -38.52 9.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.403 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -62.97 -37.57 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.4 m-85 -85.64 -5.0 59.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.47 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -81.56 -38.17 26.57 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.525 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.2 -50.82 78.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.3 47.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.121 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -73.66 61.61 0.74 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.648 0.261 . . . . 0.0 111.366 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -57.36 -43.65 83.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.102 0.477 . . . . 0.0 109.767 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.411 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.411 ' N ' ' OG ' ' A' ' 65' ' ' SEP . 0.8 OUTLIER -89.62 175.1 7.4 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -79.96 36.44 0.34 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.143 0.497 . . . . 0.0 110.857 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' THR . 2.0 m-70 -81.48 123.99 29.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.831 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.58 137.4 50.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.501 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.9 t -103.99 125.54 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.821 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 71' ' ' LEU . 23.6 tp -92.61 120.73 33.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.706 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -101.93 140.94 35.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.432 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -123.23 130.15 52.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -75.29 111.59 10.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.704 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.77 -38.62 96.45 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.029 -1.428 . . . . 0.0 110.832 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' HD12 ' A' ' 67' ' ' LEU . 5.5 pt20 -145.35 153.44 41.24 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 pt -142.32 145.89 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.799 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.8 130.09 44.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.374 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.23 116.03 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -91.48 107.96 19.57 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.78 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.7 p -73.06 171.85 12.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.082 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 50.6 tp -81.09 -27.44 35.64 Favored 'General case' 0 C--O 1.23 0.061 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.046 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -69.75 -14.3 62.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.55 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 9.25 46.98 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.58 132.01 37.22 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -104.27 125.19 50.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.9 tt -131.24 128.25 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.27 0.557 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.8 m -83.22 146.44 28.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.359 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.32 134.71 53.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.628 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -101.08 126.74 47.8 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.715 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.9 p -155.17 176.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.715 ' N ' HG22 ' A' ' 17' ' ' VAL . 42.7 mt-10 -100.54 147.38 33.53 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.421 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.92 -23.1 41.36 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.417 1.411 . . . . 0.0 112.018 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.1 p -87.6 -3.91 58.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.888 0.375 . . . . 0.0 110.494 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 18.0 t0 -64.2 151.95 42.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.16 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -87.99 169.96 11.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.292 0.568 . . . . 0.0 110.618 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.9 mm -70.27 -50.56 45.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.539 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -46.12 -26.86 0.83 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.165 0.507 . . . . 0.0 109.861 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 52.9 t-20 -73.44 -61.37 1.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.142 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -45.82 -28.41 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.422 0.63 . . . . 0.0 110.351 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -72.99 -49.26 29.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.771 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.37 61.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.568 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HZ2' ' HB ' ' A' ' 17' ' ' VAL . 46.8 mttt -64.66 -64.45 0.87 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.828 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.4 mt -51.41 -40.65 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.224 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 35' ' ' GLY . 20.7 tm0? -60.96 -60.9 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -50.19 -36.72 31.76 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.903 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -79.68 -41.33 27.08 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -112.08 9.8 20.31 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 19.56 27.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.792 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -85.56 123.38 72.77 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.25 0.525 . . . . 0.0 110.767 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.5 Cg_endo -76.36 130.68 12.12 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.705 1.603 . . . . 0.0 112.182 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -42.99 -14.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.512 2.141 . . . . 0.0 113.008 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 37' ' ' PRO . 98.3 m-20 -80.53 -40.2 26.42 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.503 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.31 -22.03 38.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.622 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -103.97 145.48 30.08 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.25 0.548 . . . . 0.0 111.937 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.93 132.27 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 mt -96.18 115.61 27.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.128 0.49 . . . . 0.0 111.306 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.2 mm -113.43 126.88 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.702 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -143.94 124.91 14.34 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.762 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 34.21 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.885 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.62 69.33 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.041 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -124.28 128.31 48.96 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.973 0.387 . . . . 0.0 110.735 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.2 130.83 38.81 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.203 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.3 mp -69.0 133.92 48.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.716 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 28.7 tt0 -72.54 131.86 43.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.301 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.53 22.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.92 17.71 0.14 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 119.478 -1.344 . . . . 0.0 113.591 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' CG ' ' N ' ' A' ' 55' ' ' THR . 43.7 ttm-85 -103.2 168.58 9.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.079 0.939 . . . . 0.0 111.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' CG ' ' A' ' 54' ' ' ARG . 28.8 p -100.65 147.5 25.91 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.334 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.3 mp -58.3 -39.01 78.21 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.422 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -44.49 -39.9 5.18 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.647 0.261 . . . . 0.0 111.376 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -63.14 -36.63 84.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 37.9 m-85 -81.4 -15.5 55.01 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.483 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.52 -47.63 46.88 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.266 0.555 . . . . 0.0 110.356 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -48.95 -52.46 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.302 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -72.84 44.75 0.13 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.145 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -76.76 61.06 1.81 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.353 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -55.41 -38.19 68.63 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 110.03 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.413 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.0 OUTLIER -89.94 177.59 6.44 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 2' ' ' GLN . 11.3 mt -81.18 38.09 0.46 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.111 0.481 . . . . 0.0 110.613 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 4.9 m-70 -82.2 125.6 31.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD12 ' H ' ' A' ' 70' ' ' VAL . 44.2 tp -112.26 140.05 47.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.556 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' H ' HD12 ' A' ' 69' ' ' LEU . 54.5 t -103.2 123.4 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.65 123.1 37.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.413 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -99.5 135.7 40.53 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 tp -122.87 130.68 53.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 110.62 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -67.82 133.33 49.02 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.1 51.86 0.24 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.726 0 CA-C-O 117.959 -1.467 . . . . 0.0 110.887 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' CG ' ' N ' ' A' ' 2' ' ' GLN . 30.1 ttp . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' N ' ' CG ' ' A' ' 1' ' ' MET . 20.8 pt20 -144.26 147.25 33.31 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.4 pt -141.0 145.29 25.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.765 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -96.15 128.07 42.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.648 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.2 t -109.41 111.99 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.05 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.3 tttp -90.33 105.72 18.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -73.28 163.96 27.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.319 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.71 -24.12 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' THR . 99.5 m -71.93 -6.97 45.76 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.689 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 10.58 60.72 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -91.89 146.51 23.69 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 m -118.18 122.82 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.604 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 13' ' ' ILE . 8.7 tt -131.57 127.55 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.6 m -83.82 146.92 27.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.357 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.54 131.98 54.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.484 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -98.63 125.41 43.9 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.735 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.6 p -154.76 176.7 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.751 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.735 ' N ' HG22 ' A' ' 17' ' ' VAL . 11.3 mm-40 -99.22 141.23 22.49 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.212 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.44 -12.09 34.48 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.471 1.448 . . . . 0.0 112.29 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 55' ' ' THR . 88.9 p -91.05 -27.22 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.114 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.515 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 36.8 m-20 -51.74 149.8 4.42 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.21 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -82.74 179.61 7.73 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.349 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.4 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.9 mm -72.75 -46.98 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.666 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 4.4 mm-40 -44.72 -26.25 0.37 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.167 0.508 . . . . 0.0 109.898 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 66.7 t30 -74.64 -62.98 1.35 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.445 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -46.32 -28.47 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.366 0.603 . . . . 0.0 110.444 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' C ' HE21 ' A' ' 31' ' ' GLN . 77.8 mttt -73.92 -50.93 17.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.394 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.67 44.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -67.09 -63.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.578 -0.449 . . . . 0.0 109.928 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.0 mt -51.05 -40.03 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.092 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.564 HE21 ' C ' ' A' ' 27' ' ' LYS . 48.0 mt-30 -58.68 -61.61 2.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.076 0.465 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -51.53 -38.51 54.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.98 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -80.63 -35.85 33.42 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 36' ' ' ILE . 5.4 mm-40 -110.25 0.67 18.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.35 16.93 16.69 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.781 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 34' ' ' GLU . 23.4 mt -92.95 114.22 62.03 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 117.314 0.557 . . . . 0.0 110.713 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.71 156.66 0.6 Allowed 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.905 1.737 . . . . 0.0 111.899 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.39 -38.07 2.16 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.537 2.158 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.167 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -81.04 -16.71 52.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.779 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -106.57 146.83 30.17 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.24 0.543 . . . . 0.0 111.792 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -131.49 128.43 39.37 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -94.01 119.55 33.05 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.12 0.486 . . . . 0.0 111.75 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.73 123.65 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.382 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -138.91 117.74 12.35 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.562 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.69 37.11 25.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.36 17.73 68.77 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.316 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -124.86 128.62 48.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.092 0.446 . . . . 0.0 110.43 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -77.62 132.7 38.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.106 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -72.97 137.73 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.142 0.496 . . . . 0.0 110.957 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.2 tt0 -74.97 134.27 41.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.406 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.59 27.85 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -167.19 19.48 0.09 OUTLIER Glycine 0 CA--C 1.532 1.132 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.825 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 55' ' ' THR . 2.6 tpp85 -105.11 170.96 7.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.14 0.97 . . . . 0.0 110.984 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 54' ' ' ARG . 35.3 p -104.12 149.76 24.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.198 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -57.63 -36.87 72.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.169 178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.7 t -47.61 -39.2 16.29 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 120.676 0.274 . . . . 0.0 111.311 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.84 -37.44 84.49 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 50.1 m-85 -86.56 -3.58 59.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.461 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -81.22 -37.96 27.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.517 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' C ' ' H ' ' A' ' 63' ' ' LYS . 90.2 mt -62.56 -52.23 62.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -71.25 45.33 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.919 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.8 pttm -82.01 58.24 3.84 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.575 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -53.29 -31.54 44.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -100.55 179.19 4.51 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.2 mt -80.04 94.54 5.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.402 0.62 . . . . 0.0 111.044 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.448 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 7.9 p-80 -133.1 118.95 19.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.892 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -105.71 130.62 53.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.525 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 47.1 t -101.72 120.5 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.88 116.39 28.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -103.55 140.29 37.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.338 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -123.87 137.33 54.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -84.24 111.9 19.8 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 110.45 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -49.32 129.34 24.23 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 118.016 -1.435 . . . . 0.0 110.923 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 30.5 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' H ' ' CG ' ' A' ' 1' ' ' MET . 8.9 pt20 -144.95 147.7 33.0 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.662 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -140.97 145.87 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -96.53 128.02 43.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.435 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.3 t -112.86 114.53 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.51 0.671 . . . . 0.0 110.26 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -90.36 106.99 18.87 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.743 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -72.31 168.32 18.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.186 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -74.97 -33.22 61.87 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.015 -179.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 57.2 m -69.27 -8.53 46.85 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.368 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.69 12.22 57.11 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -91.03 115.07 27.72 Favored 'General case' 0 C--N 1.334 -0.109 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -91.2 123.06 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.582 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.8 tt -131.84 128.72 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -83.31 147.67 27.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.435 0.636 . . . . 0.0 111.36 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.93 134.83 53.44 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.577 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -100.13 125.4 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.722 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -154.6 177.34 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.811 0.815 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.722 ' N ' HG22 ' A' ' 17' ' ' VAL . 51.8 mt-10 -99.69 147.44 33.4 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.192 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.88 -19.83 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.367 1.378 . . . . 0.0 112.07 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -91.33 -4.65 55.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.611 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.77 151.91 40.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.092 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -85.29 171.73 11.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.147 0.499 . . . . 0.0 110.474 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -73.24 -51.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.569 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 3.6 mm-40 -48.36 -23.62 0.98 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.226 0.536 . . . . 0.0 109.732 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -74.88 -61.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.0 t -48.34 -25.49 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-O 121.173 0.511 . . . . 0.0 110.266 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -71.66 -49.52 39.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.525 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -34.94 59.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.503 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -65.9 -63.51 1.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.1 mt -51.84 -39.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.8 tt0 -59.42 -60.58 3.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.171 0.51 . . . . 0.0 110.432 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.19 -35.74 17.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.674 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -83.58 -40.58 18.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -106.7 4.25 27.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.67 20.48 39.41 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.907 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.5 mt -93.94 111.25 52.2 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.39 0.595 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.44 157.53 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.888 1.725 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.31 -47.89 1.42 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.671 2.247 . . . . 0.0 112.909 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -66.15 -20.31 66.11 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.969 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -80.79 -22.43 40.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.699 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.72 146.34 26.64 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.032 0.444 . . . . 0.0 112.118 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.71 ' HE ' ' NE2' ' A' ' 49' ' ' GLN . 37.1 ttt180 -123.15 120.9 34.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -94.67 115.94 28.15 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 111.425 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -110.23 121.03 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -142.29 125.43 16.37 Favored 'General case' 0 N--CA 1.461 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.95 28.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.792 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.72 18.19 58.89 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -125.42 130.67 52.33 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.046 0.423 . . . . 0.0 110.844 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.71 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 39.2 mt-30 -76.23 131.45 39.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.982 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.5 mp -68.52 134.97 50.85 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.781 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -70.31 131.68 44.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.191 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -61.53 16.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.32 20.62 0.28 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.7 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -103.83 171.34 7.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 118.019 0.91 . . . . 0.0 111.111 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -104.45 149.57 25.31 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.052 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' TYR . 9.2 mp -56.76 -36.97 70.42 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.331 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.7 t -44.79 -39.77 5.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.536 0.208 . . . . 0.0 111.292 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -63.37 -37.58 87.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.9 m-85 -86.28 -3.57 59.0 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.419 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -82.57 -41.9 18.98 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.711 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 62' ' ' GLN . 14.2 tt -60.94 -48.08 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' N ' HG23 ' A' ' 61' ' ' ILE . 47.6 mt-30 -71.11 45.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.917 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.0 pttp -75.82 58.95 1.17 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.568 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -56.03 -40.27 73.21 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.061 0.458 . . . . 0.0 109.773 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.434 ' O3P' ' NE2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.04 176.88 6.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.8 mt -80.89 40.41 0.53 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.122 0.487 . . . . 0.0 110.96 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 68' ' ' HIS . 4.0 p-80 -82.29 123.82 29.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.048 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 70' ' ' VAL . 36.3 tp -113.79 138.19 50.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.355 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.449 ' H ' HD12 ' A' ' 69' ' ' LEU . 55.7 t -102.32 123.14 55.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.6 tp -98.16 129.18 44.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.381 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -140.71 169.19 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.4 148.17 40.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.42 138.0 56.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.422 ' O ' ' OXT' ' A' ' 76' ' ' GLY . . . 69.12 -128.86 23.04 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' OXT' ' O ' ' A' ' 75' ' ' GLY . . . . . . . . 0 C--O 1.22 -0.775 0 CA-C-O 117.99 -1.45 . . . . 0.0 110.853 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.7 113.32 6.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.507 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -100.49 148.45 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.892 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -96.67 130.2 43.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.711 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.6 113.51 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.635 0.731 . . . . 0.0 110.35 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -90.19 107.86 19.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.778 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.9 p -72.88 166.92 22.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.162 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.9 mp -71.42 -31.99 67.87 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.985 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -69.47 -7.43 37.92 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.468 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.49 14.36 58.6 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -92.15 118.85 31.24 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -90.1 121.09 31.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.673 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.3 tt -128.24 126.75 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 m -83.25 145.43 29.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.415 0.626 . . . . 0.0 111.317 -178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.66 130.06 53.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.636 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -95.78 124.16 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -152.3 173.39 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 122.018 0.913 . . . . 0.0 110.87 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 92.7 mt-10 -101.06 140.05 20.99 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.348 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.58 -6.1 13.04 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.474 1.449 . . . . 0.0 112.268 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.4 t -97.26 -28.65 13.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.32 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -51.49 146.71 6.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.017 0.437 . . . . 0.0 110.217 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.69 178.36 8.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.455 0.645 . . . . 0.0 110.255 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mm -72.71 -32.34 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.76 -24.4 49.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.221 0.534 . . . . 0.0 109.71 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -79.58 -59.98 2.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.421 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -48.57 -25.92 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -74.01 -52.66 12.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.482 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -34.49 61.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.02 -65.65 0.64 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.022 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -51.88 -40.32 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.1 tt0 -62.32 -60.28 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 110.406 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -52.52 -39.12 60.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -77.39 -43.88 31.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -105.04 6.28 33.22 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.51 22.77 40.06 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.767 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.06 114.64 65.01 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.417 0.609 . . . . 0.0 110.734 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -45.8 157.76 0.32 Allowed 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.937 1.758 . . . . 0.0 111.786 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.92 -48.77 0.27 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.564 2.176 . . . . 0.0 112.796 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -60.43 -20.57 60.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.803 0.335 . . . . 0.0 110.883 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -80.96 -21.51 40.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.65 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -107.53 149.92 27.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.172 0.511 . . . . 0.0 111.942 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' CD ' ' A' ' 49' ' ' GLN . 28.3 mmm-85 -131.94 128.51 38.64 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.8 mt -94.17 117.18 29.74 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.391 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.8 mm -108.75 122.39 63.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.474 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -140.82 125.81 18.31 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.557 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 36.26 14.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.34 18.15 67.1 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.62 127.15 47.84 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.092 0.446 . . . . 0.0 110.597 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' CD ' HH11 ' A' ' 42' ' ' ARG . 26.1 mt-30 -76.85 132.41 39.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.3 mp -70.18 135.31 48.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.943 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' GLY . 26.5 tt0 -72.49 134.09 45.13 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.265 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -62.5 15.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -155.36 19.8 0.54 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 119.61 -1.281 . . . . 0.0 113.6 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 46.2 mtt-85 -107.71 174.92 5.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.108 0.954 . . . . 0.0 111.07 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -107.88 151.97 25.04 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.08 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.6 mp -58.13 -36.72 73.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.19 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -45.96 -39.78 9.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.663 0.268 . . . . 0.0 111.294 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.26 -37.99 89.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -86.33 -3.4 58.98 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.427 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.25 -35.94 24.95 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.788 0.328 . . . . 0.0 110.387 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' C ' ' H ' ' A' ' 63' ' ' LYS . 95.1 mt -63.85 -49.85 80.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -69.64 46.33 0.07 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttp -73.18 61.7 0.63 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.621 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -56.08 -43.02 77.59 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.61 -179.48 5.19 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 mt -79.88 45.63 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.777 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.88 116.08 22.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.048 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.66 130.87 54.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.516 -179.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.691 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.1 t -103.41 119.62 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' O ' HD11 ' A' ' 8' ' ' LEU . 14.7 tp -89.33 120.8 31.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.865 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -103.64 140.52 37.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.22 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -123.37 134.73 53.97 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.526 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -81.43 122.35 27.4 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.83 0.348 . . . . 0.0 110.666 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -55.92 26.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.948 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -144.95 147.97 33.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 pt -140.29 146.52 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.98 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -96.41 128.45 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.645 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -111.38 116.33 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.469 0.652 . . . . 0.0 110.34 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -92.97 106.06 18.08 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.765 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.8 p -74.87 166.29 23.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.66 -32.12 67.56 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.413 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.1 p -70.03 0.18 6.48 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.589 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.46 80.8 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -90.03 117.1 28.57 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.6 m -98.44 126.25 43.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.497 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 13' ' ' ILE . 12.2 pt -135.46 134.83 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.108 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -82.7 146.83 28.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.355 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.57 135.07 52.84 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.754 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -98.47 125.35 43.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 18' ' ' GLU . 2.5 p -148.86 167.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.929 0.871 . . . . 0.0 110.808 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' HG22 ' A' ' 17' ' ' VAL . 31.3 mt-10 -100.28 130.68 25.4 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.78 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.58 -36.09 23.95 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.162 1.241 . . . . 0.0 112.173 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -79.4 3.67 17.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 110.812 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -72.5 148.89 44.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.12 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -88.88 168.98 11.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 110.612 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.8 mm -70.69 -50.71 42.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.59 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -45.12 -24.71 0.27 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.288 0.566 . . . . 0.0 109.76 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' N ' ' C ' ' A' ' 23' ' ' ILE . 13.7 t30 -76.58 -60.77 2.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.169 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -48.33 -25.61 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.157 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -72.39 -50.38 26.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.492 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.02 -33.91 53.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.605 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -69.42 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.1 mt -51.49 -39.4 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 55.2 tt0 -57.85 -58.97 6.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.0 110.263 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -49.79 -36.73 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.739 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -83.52 -42.97 16.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -101.92 -1.43 32.04 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.65 21.66 22.55 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.866 178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -86.59 113.71 54.16 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 117.406 0.603 . . . . 0.0 110.66 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.9 126.59 11.26 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.816 1.677 . . . . 0.0 112.218 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -41.51 -51.02 4.42 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.711 2.274 . . . . 0.0 113.081 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.81 -27.95 67.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.176 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.91 -16.6 40.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.75 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -96.01 137.17 35.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.92 0.39 . . . . 0.0 111.858 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.6 mmm-85 -125.45 122.84 37.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -98.37 123.58 42.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.195 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.0 mm -118.79 128.9 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.65 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.95 130.49 20.05 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.722 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.5 34.62 12.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.77 68.77 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.388 -0.434 . . . . 0.0 112.28 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 130.66 52.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.003 0.402 . . . . 0.0 110.648 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -74.8 129.6 37.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.983 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -67.06 133.78 50.57 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.699 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 53' ' ' GLY . 20.5 tt0 -72.72 131.48 42.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.501 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -62.17 24.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -166.13 19.35 0.1 OUTLIER Glycine 0 CA--C 1.533 1.2 0 C-N-CA 119.423 -1.37 . . . . 0.0 113.711 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.55 170.75 7.76 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.17 0.985 . . . . 0.0 110.987 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 p -103.06 147.81 26.5 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.154 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -58.05 -37.67 74.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.392 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -46.07 -38.39 7.93 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.485 0.183 . . . . 0.0 111.294 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -64.15 -37.36 87.18 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 56' ' ' LEU . 69.8 m-85 -82.01 -12.11 58.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.615 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.16 -48.99 18.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 63' ' ' LYS . 93.1 mt -48.15 -53.39 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -70.83 45.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.059 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 61' ' ' ILE . 31.0 pttt -78.96 59.19 2.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.491 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -52.73 -34.58 53.23 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.52 177.64 5.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.0 mp -80.67 97.82 7.42 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.57 0.7 . . . . 0.0 111.013 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -143.58 126.52 16.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.03 179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 70' ' ' VAL . 45.4 tp -113.09 141.15 47.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.45 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.4 t -101.87 125.41 56.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tp -95.42 120.27 35.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.279 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -126.39 153.81 44.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -123.22 158.45 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.773 0.32 . . . . 0.0 110.358 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -76.78 160.15 29.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.639 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.84 -56.85 2.19 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.845 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -143.92 145.61 32.39 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.656 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -142.16 146.43 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -95.86 129.22 43.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.521 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -111.67 115.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.419 0.628 . . . . 0.0 110.309 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -91.9 105.59 17.81 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.729 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.6 p -72.82 173.87 8.52 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.172 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.0 mm? -77.69 -32.33 53.0 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.194 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 9' ' ' THR . 89.1 m -69.99 -2.09 11.62 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.564 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.21 14.92 67.91 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -91.77 122.82 34.66 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.7 m -94.64 121.06 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.517 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.6 tt -128.0 128.14 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -82.83 144.81 29.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.517 0.675 . . . . 0.0 111.162 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.07 128.59 53.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.837 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.4 123.32 41.2 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.7 p -154.94 177.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 110.814 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.723 ' N ' HG22 ' A' ' 17' ' ' VAL . 34.5 mp0 -99.78 148.91 35.42 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.231 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.49 -19.86 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.444 1.43 . . . . 0.0 112.081 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' HG22 ' A' ' 55' ' ' THR . 95.1 p -82.36 -30.08 30.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.426 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' ' OE1' ' A' ' 18' ' ' GLU . 39.7 m-20 -50.68 145.18 7.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.933 0.397 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.8 p -83.09 -176.7 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.448 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -70.31 -40.15 77.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.572 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 59.4 mm-40 -47.01 -29.8 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.127 0.489 . . . . 0.0 109.699 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -73.62 -62.24 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.372 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -49.65 -24.4 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.363 0.601 . . . . 0.0 110.338 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HZ3' ' CG2' ' A' ' 23' ' ' ILE . 21.8 mmtm -76.19 -54.75 6.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.402 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.29 -34.15 56.15 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.618 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -66.14 -65.05 0.73 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.937 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -51.3 -39.8 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 35' ' ' GLY . 64.3 tt0 -62.49 -61.02 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.054 0.454 . . . . 0.0 110.496 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -51.15 -38.49 52.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.86 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -80.19 -46.65 15.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -103.16 1.42 33.16 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.11 25.89 33.43 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.643 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.4 mt -89.86 111.27 45.38 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 117.581 0.691 . . . . 0.0 110.762 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -49.59 123.92 11.28 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.869 1.713 . . . . 0.0 112.034 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -44.12 -35.68 7.97 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.523 2.149 . . . . 0.0 112.803 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.52 -28.79 65.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -78.98 -21.86 46.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.355 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -113.77 151.48 31.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.263 0.554 . . . . 0.0 111.897 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.63 ' NE ' ' NE2' ' A' ' 49' ' ' GLN . 19.3 ttt180 -131.75 133.02 44.33 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.497 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 9.5 mt -88.96 116.43 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.21 0.529 . . . . 0.0 111.762 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.42 124.31 68.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.546 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -142.09 116.9 9.84 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.428 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.02 37.18 24.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.83 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.15 17.83 66.3 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.127 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -124.51 128.28 48.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.09 0.445 . . . . 0.0 110.546 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.63 ' NE2' ' NE ' ' A' ' 42' ' ' ARG . 97.4 mt-30 -75.97 129.21 36.54 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.063 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.4 mp -68.39 136.31 53.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.014 0.435 . . . . 0.0 110.724 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' CB ' ' HE ' ' A' ' 54' ' ' ARG . 22.1 tt0 -73.41 130.96 41.24 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.523 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 22.4 m-20 -66.55 16.96 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -150.53 14.1 0.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.701 -1.238 . . . . 0.0 113.72 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.485 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 52.1 mtm180 -106.62 175.9 5.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.016 0.908 . . . . 0.0 111.24 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' SER . 41.5 p -106.26 148.62 27.76 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.858 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.2 mp -56.71 -36.29 69.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.313 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.6 m -47.02 -38.59 11.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.592 0.235 . . . . 0.0 111.33 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.15 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 56' ' ' LEU . 60.1 m-85 -81.32 -10.1 59.63 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.511 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -76.85 -47.79 20.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 110.414 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -49.09 -48.31 17.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.4 44.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.201 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -79.98 58.34 2.89 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.642 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -53.79 -33.83 57.2 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -97.17 177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.06 98.36 7.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.298 0.57 . . . . 0.0 110.883 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 5.1 p-80 -142.85 124.15 14.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.857 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -111.74 134.88 53.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.318 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.9 t -105.18 124.04 59.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.987 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.624 ' O ' HD21 ' A' ' 8' ' ' LEU . 6.9 mp -91.51 123.97 35.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -101.6 141.0 35.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.189 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 74' ' ' ARG . 1.0 OUTLIER -119.95 126.54 51.12 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.651 ' N ' HD23 ' A' ' 73' ' ' LEU . 32.5 mmm-85 -63.81 131.2 47.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.841 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.87 102.49 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.788 0 CA-C-O 117.941 -1.477 . . . . 0.0 110.94 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.4 ptt? . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -145.31 152.76 40.42 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.064 0.459 . . . . 0.0 110.441 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.1 pt -142.77 146.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.81 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -95.96 129.29 43.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.02 114.24 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.568 0.699 . . . . 0.0 110.44 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -91.66 104.49 16.95 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.499 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -74.05 167.46 21.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.222 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 8' ' ' LEU . 3.3 mm? -73.96 -32.4 63.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.474 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -70.18 1.51 4.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.503 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.47 12.1 80.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -90.9 112.91 24.96 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -97.53 126.2 42.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.492 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.71 138.01 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.224 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.4 m -82.13 146.75 29.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.377 0.608 . . . . 0.0 111.203 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.33 129.73 54.11 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.767 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -95.21 121.78 37.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.4 p -153.24 173.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.65 0.738 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.689 ' N ' HG22 ' A' ' 17' ' ' VAL . 58.5 mm-40 -94.55 138.46 22.31 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.592 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 57' ' ' SER . 50.4 Cg_endo -67.74 -0.53 5.43 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.596 1.531 . . . . 0.0 111.99 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.439 ' O ' HG22 ' A' ' 55' ' ' THR . 97.6 p -105.8 -24.48 12.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.333 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -51.08 153.29 1.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.994 0.426 . . . . 0.0 110.133 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -82.52 175.56 10.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm -71.98 -46.86 57.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.463 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -46.42 -25.47 0.67 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 109.75 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 25' ' ' ASN . 0.1 OUTLIER -74.76 -61.67 1.8 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.289 178.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -47.27 -27.59 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.367 0.604 . . . . 0.0 110.552 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -72.59 -50.75 23.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.633 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.87 -33.78 38.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.494 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -67.45 -63.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.981 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -50.24 -40.04 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' GLY . 78.1 mt-30 -59.59 -60.36 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -52.17 -37.68 55.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.941 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -78.09 -46.28 21.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -108.5 4.14 23.87 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.7 25.32 35.72 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.646 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.1 mt -90.45 111.81 49.43 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 117.533 0.666 . . . . 0.0 110.775 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.78 158.28 1.25 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.868 1.712 . . . . 0.0 111.942 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.27 -52.56 0.35 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.619 2.212 . . . . 0.0 112.705 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.4 -18.54 39.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -82.44 -27.66 31.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.629 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 14.1 pt20 -113.09 150.69 31.73 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.399 0.618 . . . . 0.0 111.843 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -131.31 131.15 43.58 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -93.37 119.48 32.54 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.131 0.491 . . . . 0.0 111.3 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.4 mm -116.72 128.95 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -143.75 124.32 14.04 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.93 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.94 35.77 22.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.11 17.0 69.45 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.148 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -123.6 125.8 45.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.012 0.406 . . . . 0.0 110.436 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -77.33 133.08 38.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.104 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.3 mp -70.96 134.01 46.84 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 53' ' ' GLY . 17.9 tt0 -73.59 133.77 43.58 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.296 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -63.23 24.93 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.2 16.78 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 119.487 -1.34 . . . . 0.0 113.612 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 169.85 8.3 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.229 1.014 . . . . 0.0 111.163 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 20' ' ' SER . 30.1 p -102.45 148.59 25.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.109 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.0 mp -57.24 -38.92 74.55 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 19' ' ' PRO . 55.6 p -49.65 -38.11 31.12 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 111.371 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.55 -37.47 86.25 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -82.96 -14.21 54.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.509 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -70.76 -47.84 57.51 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.025 0.441 . . . . 0.0 110.189 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -50.13 -50.99 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -73.74 44.56 0.17 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.271 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -76.29 59.75 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.486 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.26 -37.86 67.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.056 0.455 . . . . 0.0 109.988 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.442 ' OG ' ' N ' ' A' ' 66' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.8 OUTLIER -93.22 178.04 5.86 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -79.8 41.25 0.49 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.212 0.529 . . . . 0.0 110.624 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.451 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.3 m-70 -81.41 120.85 25.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.4 -0.818 . . . . 0.0 108.895 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -107.77 136.54 47.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.626 -178.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.575 ' H ' HD13 ' A' ' 69' ' ' LEU . 63.7 t -114.98 125.21 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 110.083 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.54 ' O ' HD21 ' A' ' 8' ' ' LEU . 8.4 mp -92.24 120.82 33.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -103.61 148.89 25.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.195 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 133.54 50.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.331 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -75.06 -47.75 27.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.646 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.22 132.07 1.56 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.911 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.3 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.34 99.37 3.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.011 0.434 . . . . 0.0 110.64 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -99.2 149.91 5.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.703 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -96.94 129.21 44.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.52 114.21 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.397 0.618 . . . . 0.0 110.189 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -90.22 106.5 18.53 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.829 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.3 p -70.55 168.15 16.93 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.145 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -74.42 -32.25 62.6 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.236 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 9' ' ' THR . 95.1 m -69.55 -12.89 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.72 12.99 39.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -90.75 127.69 36.42 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -102.07 121.7 42.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.573 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 13' ' ' ILE . 9.6 tt -130.12 128.86 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -82.58 143.9 30.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.519 0.675 . . . . 0.0 111.104 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -122.53 133.66 54.57 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.695 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 1.3 mp0 -100.05 124.75 45.77 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.4 p -150.08 169.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.393 0.616 . . . . 0.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.629 ' N ' HG22 ' A' ' 17' ' ' VAL . 40.3 mt-10 -91.26 142.37 27.08 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.4 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 -6.13 15.76 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.265 1.31 . . . . 0.0 112.141 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.8 p -103.17 -22.42 13.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.471 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -51.85 148.95 5.22 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.907 0.384 . . . . 0.0 110.548 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -82.72 177.7 8.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.129 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.9 mm -72.14 -43.61 66.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.647 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' A' ' 52' ' ' ASP . 41.8 mm-40 -48.38 -26.81 2.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.148 0.499 . . . . 0.0 109.682 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -73.69 -62.29 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.334 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.6 t -46.28 -27.81 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.304 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -73.92 -50.74 18.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.414 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.16 60.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.567 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -65.33 -65.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.907 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -51.17 -41.09 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 66.6 tt0 -58.76 -61.33 2.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.122 0.486 . . . . 0.0 110.463 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -50.89 -36.79 39.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.967 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.44 -43.55 23.09 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -105.49 5.74 31.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -177.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.97 21.48 38.03 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.732 178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 19.8 mt -96.57 113.93 63.53 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 117.362 0.581 . . . . 0.0 110.649 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.01 155.69 0.57 Allowed 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.899 1.732 . . . . 0.0 111.936 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.71 -43.07 0.96 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.624 2.216 . . . . 0.0 112.725 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.74 -22.85 67.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -81.45 -18.83 43.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.679 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 50.1 mt-30 -102.56 145.13 30.07 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.364 0.602 . . . . 0.0 111.825 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -124.77 121.22 33.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -93.61 118.57 31.54 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.138 0.494 . . . . 0.0 111.617 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mm -113.25 122.43 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.525 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -142.61 126.73 17.43 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.617 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.52 34.14 22.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.001 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.59 65.32 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.135 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -124.64 130.14 51.87 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.146 0.473 . . . . 0.0 110.781 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.35 132.45 39.76 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.062 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -69.47 133.64 47.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 110.881 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.9 tt0 -68.62 138.41 55.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.233 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.434 ' O ' ' OE2' ' A' ' 24' ' ' GLU . 24.1 t70 -61.81 13.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -162.03 26.2 0.24 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.756 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -102.58 168.32 9.35 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.968 0.884 . . . . 0.0 111.216 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -101.24 148.06 25.55 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.955 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.5 mp -56.83 -39.32 74.01 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.348 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 t -45.21 -39.76 6.63 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.623 0.249 . . . . 0.0 111.369 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -63.27 -38.14 90.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 56' ' ' LEU . 64.2 m-85 -84.99 -4.0 58.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.528 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -83.98 -36.79 22.94 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.58 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.22 -48.89 85.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -69.91 47.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.115 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -78.37 59.3 2.32 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -55.97 -38.87 70.98 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 0.9 OUTLIER -90.97 175.34 7.0 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.12 41.51 0.45 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.216 0.532 . . . . 0.0 110.997 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 5.2 m-70 -83.54 121.39 27.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.063 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.3 tp -110.92 136.44 49.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.299 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HD12 ' A' ' 69' ' ' LEU . 56.0 t -103.36 122.83 56.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.2 tp -91.66 119.2 31.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' C ' HD12 ' A' ' 73' ' ' LEU . 7.7 mmm180 -107.19 144.98 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.381 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 72' ' ' ARG . 10.5 mp -107.41 142.78 36.71 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.79 0.329 . . . . 0.0 110.277 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -66.46 118.04 9.53 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.625 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.29 -162.11 32.55 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.738 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.817 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -147.08 111.19 5.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.692 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 pt -100.16 147.94 7.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -96.32 126.4 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.633 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.58 114.22 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.498 0.666 . . . . 0.0 110.249 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -91.57 108.25 19.77 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.844 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.0 p -72.37 169.99 15.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.127 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -81.47 -27.78 34.43 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.16 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -69.68 -3.3 14.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.517 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.36 8.09 63.03 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -92.51 142.47 27.37 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -122.93 127.11 48.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.751 0.31 . . . . 0.0 110.427 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 pt -136.34 136.06 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 109.972 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.9 m -81.76 146.01 30.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.508 0.67 . . . . 0.0 111.291 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.59 130.73 54.31 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.694 -178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -97.65 122.29 40.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.717 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.9 p -154.73 175.59 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.695 0.759 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.717 ' N ' HG22 ' A' ' 17' ' ' VAL . 43.2 mt-10 -96.9 137.8 21.33 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.32 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.5 -6.52 16.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.501 1.468 . . . . 0.0 112.212 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 89.9 p -97.18 -25.54 15.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.282 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -50.91 153.06 1.91 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 0.0 110.209 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.4 p -82.22 179.33 7.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.473 0.654 . . . . 0.0 110.218 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 mm -73.56 -45.75 50.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.484 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -45.6 -25.99 0.54 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -74.28 -63.15 1.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.173 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -46.79 -27.17 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.194 0.521 . . . . 0.0 110.437 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -73.03 -50.62 22.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.552 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.8 -35.42 56.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.559 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -66.67 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.086 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.68 -39.92 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.9 tt0 -60.08 -60.23 4.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 110.468 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.03 -36.03 27.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.805 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.47 -46.96 15.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -104.89 5.49 32.96 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.21 24.96 38.28 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.575 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -94.13 109.97 45.37 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 117.541 0.67 . . . . 0.0 110.779 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.28 157.55 3.05 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.882 1.721 . . . . 0.0 111.872 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.65 -31.62 20.65 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.558 2.172 . . . . 0.0 112.605 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -77.27 -25.36 51.33 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.874 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -77.16 -22.48 52.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.376 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.4 159.35 26.34 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.423 0.63 . . . . 0.0 111.613 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -132.44 135.29 45.97 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 44' ' ' ILE . 15.8 mt -90.61 115.59 27.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.214 0.53 . . . . 0.0 111.455 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.563 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -108.78 121.69 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.345 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -140.27 120.52 13.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.729 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.22 39.32 28.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.954 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.4 17.74 60.05 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.145 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' CB ' ' NZ ' ' A' ' 48' ' ' LYS . 9.3 mtmp? -124.9 130.39 52.28 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.045 0.422 . . . . 0.0 110.553 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -78.78 132.25 36.84 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.114 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.6 mp -69.37 136.95 52.42 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.084 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -66.18 147.19 53.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.326 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.63 12.82 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.78 30.01 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.854 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -104.37 168.94 8.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.092 0.946 . . . . 0.0 111.06 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 20' ' ' SER . 33.2 p -103.54 149.65 24.67 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.216 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.76 -39.16 73.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.519 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.1 p -46.56 -38.74 9.88 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 120.649 0.261 . . . . 0.0 111.442 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -63.09 -38.42 91.1 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -82.94 -9.19 59.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.537 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -75.18 -47.33 28.89 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.1 -49.33 28.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -76.36 43.93 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.29 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -76.71 59.91 1.62 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.582 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -54.59 -37.01 65.02 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.498 ' OG1' ' CD2' ' A' ' 68' ' ' HIS . 1.1 p -92.53 179.59 5.47 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.71 40.23 0.51 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.2 0.524 . . . . 0.0 110.9 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CD2' ' OG1' ' A' ' 66' ' ' THR . 3.8 m-70 -83.18 123.93 30.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.003 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.3 tp -112.09 136.95 50.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.468 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.7 t -103.61 124.09 57.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 tp -92.3 119.79 32.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.019 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -101.27 139.94 36.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -123.58 133.52 53.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.596 0.236 . . . . 0.0 110.4 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -73.59 139.53 45.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.71 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.52 -160.01 23.0 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.757 0 CA-C-O 118.039 -1.423 . . . . 0.0 111.003 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -144.97 98.87 3.24 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -99.39 151.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.928 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -97.2 128.44 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.709 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.34 115.7 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.483 0.658 . . . . 0.0 110.11 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -91.95 105.32 17.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.716 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -73.72 171.03 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.987 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -80.26 -30.33 38.43 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.139 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -69.53 -1.39 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.521 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.51 9.16 72.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.7 mptp? -90.1 121.61 32.32 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.1 m -105.02 125.5 51.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.384 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.43 137.56 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.131 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -82.18 146.6 29.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.402 0.62 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' NZ ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -120.65 130.76 54.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.663 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -96.45 122.55 39.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 1.7 p -149.15 166.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.656 0.741 . . . . 0.0 110.765 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 64.7 mt-10 -94.84 140.84 22.67 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.604 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.92 -10.16 24.19 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.395 1.397 . . . . 0.0 112.181 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 55' ' ' THR . 31.4 t -94.52 -28.39 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.126 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -51.27 146.33 6.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.195 0.522 . . . . 0.0 110.558 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -82.08 179.83 7.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.094 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 9.1 mm -74.22 -41.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.711 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -48.5 -23.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -78.34 -60.62 2.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.151 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.2 t -46.44 -29.77 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.314 0.578 . . . . 0.0 110.419 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.541 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 48.8 mttp -71.54 -50.3 32.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.493 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.75 26.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.693 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -68.31 -62.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.9 mt -50.32 -42.22 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.0 mt-30 -60.08 -60.13 4.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.101 0.477 . . . . 0.0 110.356 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -50.06 -38.62 39.03 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.885 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' NZ ' HD12 ' A' ' 15' ' ' LEU . 86.6 mttt -78.19 -47.69 17.5 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -106.42 6.16 30.09 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.58 16.82 7.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.609 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.1 mt -83.13 113.48 46.28 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.391 0.596 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.09 158.48 0.89 Allowed 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 121.917 1.744 . . . . 0.0 111.759 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.4 -48.33 0.43 Allowed 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.581 2.187 . . . . 0.0 112.914 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.92 -21.06 66.3 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.961 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -79.79 -23.2 42.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.553 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.87 153.1 28.43 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.316 0.579 . . . . 0.0 111.723 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -129.0 128.79 44.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -93.58 119.05 32.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 111.623 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.3 mm -112.77 122.82 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.69 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.47 126.03 15.88 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.535 179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.97 31.98 18.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.987 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.26 16.16 68.71 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.17 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -124.62 131.12 53.49 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 117.062 0.431 . . . . 0.0 110.683 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -75.06 131.23 40.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.079 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.1 mp -69.77 132.1 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.023 0.44 . . . . 0.0 110.89 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 53' ' ' GLY . 58.8 tt0 -72.1 134.61 45.88 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.334 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -61.5 17.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -159.76 20.58 0.26 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.675 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -103.99 169.35 8.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.095 0.947 . . . . 0.0 111.115 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 20' ' ' SER . 33.5 p -102.71 149.45 24.45 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.218 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.3 mp -58.12 -37.52 74.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.343 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -48.13 -38.58 18.2 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.706 0.289 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 93.6 m-20 -63.91 -38.59 91.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -83.01 -8.29 59.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.53 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -76.87 -46.99 22.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.264 0.554 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 62' ' ' GLN . 2.5 pt -50.01 -47.69 23.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.494 ' H ' HG13 ' A' ' 61' ' ' ILE . 88.8 mt-30 -76.67 43.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.832 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -78.46 59.29 2.36 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -55.08 -35.48 64.62 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -90.94 176.48 6.59 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -80.01 39.57 0.44 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.29 0.567 . . . . 0.0 110.999 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -82.76 124.83 30.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.241 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 33.9 tp -110.17 136.31 49.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.42 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 63.6 t -103.96 123.02 57.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -94.26 120.01 33.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.047 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -102.73 143.35 32.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.231 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tp -118.83 137.01 53.71 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.664 0.268 . . . . 0.0 110.524 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -79.15 133.52 36.73 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.631 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.19 -178.51 46.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.718 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.825 -179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' N ' ' SD ' ' A' ' 1' ' ' MET . 19.1 pt20 -147.64 167.08 25.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.1 pt -142.65 146.29 22.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.685 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -97.4 129.04 44.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.8 t -111.12 115.71 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.396 0.617 . . . . 0.0 110.152 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -92.19 105.34 17.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.735 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.5 p -71.31 167.84 18.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.038 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 tp -75.76 -30.92 59.31 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.205 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 9' ' ' THR . 61.8 m -69.55 -10.96 60.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.429 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.48 11.13 54.74 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -91.05 115.7 28.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -91.58 123.53 35.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.459 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.3 tt -132.25 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.047 0.451 . . . . 0.0 109.917 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.0 m -83.65 144.85 29.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.505 0.669 . . . . 0.0 111.156 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 130.13 54.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.742 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -96.71 123.21 40.32 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.3 p -152.88 174.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.487 0.661 . . . . 0.0 110.859 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 17' ' ' VAL . 38.8 mt-10 -96.39 138.98 21.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.351 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 57' ' ' SER . 54.0 Cg_endo -66.84 -5.57 13.64 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 121.537 1.491 . . . . 0.0 112.316 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 55' ' ' THR . 67.7 m -99.83 -26.79 13.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.079 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -50.84 151.4 2.5 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.973 0.416 . . . . 0.0 110.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -83.04 178.8 7.98 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.557 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -73.02 -47.33 48.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.565 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -44.33 -26.54 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.228 0.537 . . . . 0.0 109.775 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.08 -61.76 1.74 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.333 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.4 t -47.72 -26.29 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.284 0.564 . . . . 0.0 110.549 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -73.78 -51.04 17.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.664 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.45 -35.46 60.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.658 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.03 -64.86 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.06 -39.75 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.4 tt0 -59.67 -60.81 3.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.168 0.509 . . . . 0.0 110.479 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -52.16 -37.01 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.029 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.57 -43.83 19.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -104.7 1.82 29.77 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.57 26.52 45.93 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.688 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.5 mt -94.3 109.83 44.95 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 117.554 0.677 . . . . 0.0 110.734 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.25 124.95 15.15 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.778 1.652 . . . . 0.0 112.102 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -43.89 -29.6 2.64 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.463 2.109 . . . . 0.0 112.975 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.88 -34.04 68.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.707 0.289 . . . . 0.0 111.126 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.72 -17.87 55.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.302 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -115.03 150.65 35.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.352 0.596 . . . . 0.0 111.545 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -133.11 136.16 45.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.3 mt -91.63 117.15 29.47 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.162 0.506 . . . . 0.0 111.38 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.03 125.48 71.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.655 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.11 118.35 11.36 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.592 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.74 40.28 26.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.04 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.52 19.3 60.02 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.153 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -123.84 127.75 48.51 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.086 0.443 . . . . 0.0 110.535 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.63 128.35 34.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.186 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.7 mp -68.37 138.44 55.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.157 0.503 . . . . 0.0 110.802 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 53' ' ' GLY . 11.1 tt0 -68.36 133.61 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.3 11.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -161.39 28.81 0.29 Allowed Glycine 0 CA--C 1.532 1.117 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.728 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -102.54 167.38 9.97 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 118.174 0.987 . . . . 0.0 111.017 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 20' ' ' SER . 40.7 p -101.39 147.54 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.335 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.2 mp -57.6 -39.28 76.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.016 -0.674 . . . . 0.0 109.232 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 19' ' ' PRO . 23.2 t -44.72 -41.17 6.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.686 0.279 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -61.65 -36.27 80.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 55.6 m-85 -86.09 -7.77 58.36 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.5 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -79.49 -39.12 32.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.809 0.338 . . . . 0.0 110.49 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' C ' ' H ' ' A' ' 63' ' ' LYS . 13.6 mm -62.05 -51.41 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -70.55 45.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.801 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 61' ' ' ILE . 17.5 pttm -83.27 58.46 4.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.766 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -53.61 -30.95 45.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 109.89 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.62 176.21 5.92 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -80.24 98.51 7.41 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 121.211 0.529 . . . . 0.0 111.116 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 23.2 p80 -143.85 126.7 16.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.164 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' H ' ' A' ' 70' ' ' VAL . 41.7 tp -113.13 138.61 49.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.262 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' H ' HD12 ' A' ' 69' ' ' LEU . 51.0 t -102.92 124.14 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LEU . 25.9 tp -94.81 120.68 35.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -100.21 139.33 36.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.296 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.5 mt -119.06 142.32 47.96 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.794 0.331 . . . . 0.0 110.35 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -75.06 -42.5 56.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.503 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.93 140.21 2.93 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 CA-C-O 117.987 -1.451 . . . . 0.0 110.894 179.943 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -145.31 153.85 41.71 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.6 pt -140.93 146.11 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.025 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -97.19 128.82 44.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.515 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -113.18 115.77 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.522 0.677 . . . . 0.0 110.274 179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -92.63 106.17 18.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.838 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.1 p -74.44 166.28 23.78 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.08 -32.24 70.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.209 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.6 p -69.68 4.97 1.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.408 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.01 14.44 82.63 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -91.57 124.08 35.46 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -98.93 122.97 42.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.6 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -130.05 130.09 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -83.87 145.85 28.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.405 0.622 . . . . 0.0 111.289 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.11 136.53 53.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.508 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -99.92 125.99 45.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.7 p -150.9 171.65 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.448 0.642 . . . . 0.0 110.821 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.678 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.1 mt-10 -102.02 148.65 35.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.49 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 -11.95 30.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.22 1.28 . . . . 0.0 112.177 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -96.01 -9.16 31.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.628 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -67.19 146.82 53.82 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.33 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.4 p -83.14 176.74 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.213 0.53 . . . . 0.0 110.192 178.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -72.97 -48.88 42.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.691 178.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 14.5 mm-40 -46.97 -24.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.305 0.574 . . . . 0.0 109.682 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -73.79 -62.93 1.32 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.218 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.2 t -45.99 -27.15 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -71.1 -48.98 49.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.606 179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.61 58.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.688 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -65.96 -64.31 0.89 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.995 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.7 mt -50.24 -39.15 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.084 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.0 tt0 -56.7 -61.17 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.454 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -50.32 -37.99 39.5 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.007 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -82.59 -42.1 18.69 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -103.83 0.23 30.03 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.04 23.24 31.14 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.843 177.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -94.0 112.02 55.45 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 117.352 0.576 . . . . 0.0 110.57 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.95 122.37 5.15 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.841 1.694 . . . . 0.0 111.833 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.87 -38.81 13.51 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.67 2.247 . . . . 0.0 113.167 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.01 -32.55 70.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.75 0.31 . . . . 0.0 111.293 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -84.03 -8.72 59.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.589 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -91.27 137.67 32.18 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.196 0.522 . . . . 0.0 111.899 -179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.722 ' HE ' ' HE ' ' A' ' 74' ' ' ARG . 27.2 mmt180 -125.62 116.72 22.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 20.2 mt -95.27 115.14 27.03 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.195 0.521 . . . . 0.0 111.456 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.5 mp -109.78 124.71 66.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.492 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -135.36 114.94 12.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.711 178.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.87 40.89 32.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.927 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.51 17.21 68.47 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.224 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -122.33 124.18 43.13 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.132 0.466 . . . . 0.0 110.48 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -77.2 131.73 38.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.124 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 50' ' ' LEU . 7.9 mp -70.2 138.66 51.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.078 0.466 . . . . 0.0 110.901 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 53' ' ' GLY . 25.6 tt0 -70.68 135.44 48.32 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.273 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 20.1 t70 -60.89 11.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.16 25.41 0.41 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 119.542 -1.314 . . . . 0.0 113.736 -179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -103.62 170.33 8.0 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 117.953 0.876 . . . . 0.0 111.325 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -103.3 148.81 25.38 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.149 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.5 mp -57.43 -39.12 75.55 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.5 t -46.06 -39.36 9.13 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.663 0.268 . . . . 0.0 111.375 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.27 -36.37 81.84 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' LEU . 75.8 m-85 -87.11 -4.46 59.14 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.369 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.62 -33.33 25.33 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' LYS . 63.2 mt -66.33 -54.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -68.44 47.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.803 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' ILE . 46.7 tttm -76.59 61.0 1.72 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -55.92 -39.2 71.32 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . 0.447 ' O2P' ' CD2' ' A' ' 68' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.6 t -93.16 176.74 6.29 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.42 45.88 0.7 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.238 0.542 . . . . 0.0 111.017 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.02 118.01 22.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.04 178.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.53 134.72 50.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.543 -179.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.693 ' N ' HD13 ' A' ' 69' ' ' LEU . 54.4 t -103.01 121.53 54.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.0 tp -94.99 121.93 37.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.036 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -119.67 150.48 40.28 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -122.78 153.14 39.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.896 0.379 . . . . 0.0 110.465 179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.722 ' HE ' ' HE ' ' A' ' 42' ' ' ARG . 97.4 mtt180 -80.07 165.41 22.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.96 -70.18 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.774 0 CA-C-O 118.02 -1.433 . . . . 0.0 110.87 -179.996 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -144.51 149.56 36.12 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 43.9 pt -143.4 146.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.786 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -98.28 130.89 44.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.658 -179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.3 t -115.08 114.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.651 0.739 . . . . 0.0 110.279 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -90.26 107.66 19.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.616 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.6 p -74.02 172.65 11.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.178 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -80.81 -26.91 36.8 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.998 -179.725 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -71.33 7.45 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.523 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . 77.75 10.85 85.96 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -92.16 148.52 22.1 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -123.19 125.02 44.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' ILE . 4.9 tt -132.12 130.82 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.06 0.457 . . . . 0.0 109.869 179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -82.71 146.06 29.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.126 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.97 130.99 53.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.577 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -97.67 124.85 42.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.9 p -154.46 176.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.845 0.831 . . . . 0.0 110.717 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.73 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.0 mt-10 -101.62 140.07 20.91 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.261 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.01 -4.67 11.88 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.491 1.46 . . . . 0.0 112.187 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.1 p -98.6 -26.88 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -51.77 151.91 3.17 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.049 0.452 . . . . 0.0 110.145 -179.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.2 p -83.33 179.9 7.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.326 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.5 mm -74.09 -48.98 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.693 178.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -43.84 -25.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 109.783 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' N ' ' C ' ' A' ' 23' ' ' ILE . 57.3 t-20 -74.11 -63.12 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.265 178.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.31 -28.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.303 0.573 . . . . 0.0 110.336 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -72.32 -50.88 23.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.562 179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -35.02 59.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.54 -179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -65.66 -64.76 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.859 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -51.03 -40.59 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.977 -179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' GLY . 62.6 tt0 -57.46 -61.59 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.133 0.492 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.18 -36.53 19.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.871 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -81.92 -39.52 23.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -106.07 4.76 29.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.88 19.1 35.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.928 178.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 20.3 mt -94.55 117.08 67.01 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 117.335 0.567 . . . . 0.0 110.638 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.66 159.66 0.2 Allowed 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 121.922 1.748 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.89 -52.75 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.571 2.181 . . . . 0.0 112.902 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -60.06 -21.48 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.936 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -81.3 -17.14 50.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.592 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 34.5 mt-30 -95.53 137.65 34.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.922 0.391 . . . . 0.0 111.847 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -118.14 117.44 29.18 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mt -92.06 113.05 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.459 . . . . 0.0 111.416 -178.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.6 mm -107.26 119.97 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.66 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -136.76 121.75 18.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.25 40.16 25.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.018 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.94 17.44 63.16 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.256 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -123.17 126.2 46.56 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.157 0.479 . . . . 0.0 110.555 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -77.38 131.51 38.09 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.066 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.33 138.1 51.17 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.834 -178.597 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.4 tt0 -69.47 134.88 49.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.232 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -61.44 12.44 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.64 25.04 0.36 Allowed Glycine 0 CA--C 1.53 1.031 0 C-N-CA 119.54 -1.314 . . . . 0.0 113.697 -179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -105.99 170.86 7.66 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.004 0.902 . . . . 0.0 111.216 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 p -103.69 150.06 24.38 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.177 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.4 mp -56.71 -36.14 69.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.203 178.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -47.03 -39.58 13.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.639 0.257 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.26 -38.01 89.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' LEU . 85.6 m-85 -86.13 -3.77 59.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.428 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -82.53 -37.18 25.56 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' LYS . 97.0 mt -62.68 -51.09 76.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -69.39 46.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.175 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ILE . 59.7 tttm -73.88 61.32 0.78 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.267 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -56.36 -43.13 78.87 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -92.19 179.07 5.67 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.6 mm? -80.14 43.67 0.63 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.314 0.578 . . . . 0.0 110.922 -178.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -83.62 119.14 24.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 70' ' ' VAL . 37.2 tp -112.02 137.01 50.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' H ' HD12 ' A' ' 69' ' ' LEU . 44.3 t -103.08 121.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.1 tp -91.63 124.41 35.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.05 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -129.5 158.54 38.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.31 154.12 34.02 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -51.14 -52.61 42.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.771 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.59 37.0 87.98 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.749 0 CA-C-O 118.007 -1.441 . . . . 0.0 110.905 -179.9 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.19 149.83 37.05 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.3 pt -141.71 145.29 24.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.754 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.03 128.23 42.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.46 -179.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -113.55 115.45 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.392 0.615 . . . . 0.0 110.367 179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -92.48 107.65 19.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.573 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.2 p -74.09 166.94 22.52 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.275 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 tt -70.81 -33.36 70.63 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.432 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -69.79 -4.27 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.399 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.21 14.84 63.49 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -92.5 114.43 26.98 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -88.18 123.59 32.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.842 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 13' ' ' ILE . 4.2 tt -131.13 129.12 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -84.43 145.48 28.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.323 -178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.81 133.65 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.568 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -99.28 124.27 44.23 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' N ' ' A' ' 18' ' ' GLU . 9.8 p -154.66 175.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.529 0.681 . . . . 0.0 110.741 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.726 ' N ' HG22 ' A' ' 17' ' ' VAL . 24.1 mt-10 -96.51 138.25 21.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.171 178.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.96 -6.28 15.54 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.447 1.431 . . . . 0.0 112.233 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -97.78 -25.88 14.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.178 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.501 ' OD2' ' ND2' ' A' ' 25' ' ' ASN . 52.0 m-20 -50.99 151.9 2.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 120.916 0.389 . . . . 0.0 110.169 -179.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -82.8 179.43 7.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.316 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -74.46 -32.98 31.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.677 178.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' OE2' ' OD1' ' A' ' 52' ' ' ASP . 40.1 mm-40 -58.23 -25.34 61.57 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.501 ' ND2' ' OD2' ' A' ' 21' ' ' ASP . 64.6 t30 -74.58 -62.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.269 178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -47.57 -23.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.349 0.595 . . . . 0.0 110.375 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -75.56 -51.71 12.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.41 179.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.56 -36.04 61.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -65.44 -64.72 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.853 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.567 HG21 HE22 ' A' ' 41' ' ' GLN . 69.3 mt -51.67 -36.06 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.645 HE22 ' N ' ' A' ' 36' ' ' ILE . 6.8 tp60 -56.5 -62.8 1.47 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.306 0.575 . . . . 0.0 110.421 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -51.23 -37.57 47.65 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.833 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -80.36 -46.55 15.89 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -99.94 -0.07 40.17 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.609 ' C ' HE22 ' A' ' 31' ' ' GLN . . . 55.73 28.13 51.39 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.918 178.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.645 ' N ' HE22 ' A' ' 31' ' ' GLN . 28.8 mt -100.22 131.79 23.61 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.402 0.601 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 39' ' ' ASP . 74.1 Cg_endo -75.36 125.23 8.95 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.992 1.795 . . . . 0.0 112.009 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -41.92 -20.43 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.452 2.101 . . . . 0.0 112.946 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' PRO . 73.8 m-20 -71.97 -43.66 64.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.174 -179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -84.6 -14.8 47.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.435 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.567 HE22 HG21 ' A' ' 30' ' ' ILE . 12.5 tt0 -93.07 135.31 34.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.259 0.552 . . . . 0.0 111.493 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -126.59 124.45 39.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.7 mt -96.88 120.3 36.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.0 111.397 -179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.14 125.21 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.592 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.52 125.75 21.58 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.631 179.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.59 39.38 24.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.943 -179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.28 17.98 64.59 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.156 179.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.81 128.66 49.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 117.115 0.457 . . . . 0.0 110.64 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -77.82 131.33 37.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 50' ' ' LEU . 9.0 mp -66.9 133.58 50.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.999 0.428 . . . . 0.0 110.588 -178.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -68.18 151.4 47.04 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.705 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD1' ' OE2' ' A' ' 24' ' ' GLU . 38.5 t70 -83.2 39.45 0.65 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.508 -179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.03 17.1 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.718 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -104.08 172.98 6.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.064 0.932 . . . . 0.0 111.02 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 p -106.97 150.89 26.0 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.178 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -55.61 -36.6 67.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 119.854 -0.739 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -46.27 -38.59 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.762 0.315 . . . . 0.0 111.183 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -63.19 -37.0 85.52 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' N ' ' O ' ' A' ' 56' ' ' LEU . 74.2 m-85 -86.51 -3.59 59.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.278 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -82.98 -38.14 23.09 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.81 0.338 . . . . 0.0 110.509 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.3 mm -64.67 -51.1 71.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -72.09 46.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.004 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.79 61.09 0.98 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.44 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -56.05 -41.4 74.98 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -92.07 177.4 6.18 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -80.92 37.78 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.128 0.49 . . . . 0.0 110.964 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -81.81 124.58 29.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.729 178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 70' ' ' VAL . 42.2 tp -114.07 140.41 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.563 -178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.5 t -102.8 126.41 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -94.16 117.49 30.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.992 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -108.83 142.4 39.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.232 178.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -120.73 151.38 39.61 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.002 0.429 . . . . 0.0 110.484 179.534 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -85.1 125.7 33.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.561 179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -140.56 21.74 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.763 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.795 179.825 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' N ' ' O ' ' A' ' 17' ' ' VAL . 22.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -143.92 147.03 33.41 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.057 0.455 . . . . 0.0 110.635 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -141.51 146.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -98.05 129.56 44.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.0 t -110.99 115.86 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.391 0.615 . . . . 0.0 110.296 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 tttm -92.24 107.33 19.14 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.59 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.9 p -72.31 166.89 21.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.086 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.85 -26.72 44.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.252 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 9' ' ' THR . 49.2 m -69.56 -9.17 52.87 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.409 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.59 8.18 56.2 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.2 m -122.33 125.3 45.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.675 0.274 . . . . 0.0 110.334 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.4 tt -133.24 132.92 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 110.054 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -83.15 144.49 29.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.224 -178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.61 131.21 53.99 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.547 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -100.31 125.6 46.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.714 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.7 p -155.1 175.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.673 0.749 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.2 mp0 -95.81 139.3 21.8 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.276 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 57' ' ' SER . 56.2 Cg_endo -68.66 -0.44 6.03 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.622 1.548 . . . . 0.0 112.206 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.0 p -105.08 -23.58 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -52.63 153.07 3.31 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.06 0.457 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -82.9 178.87 7.96 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.487 0.661 . . . . 0.0 110.351 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -72.69 -44.04 60.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.563 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -46.34 -28.62 1.37 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.276 0.56 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -72.09 -64.1 1.01 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.249 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -45.16 -29.58 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 110.376 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -73.39 -49.13 28.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.52 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.5 -35.52 60.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.585 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -67.0 -64.9 0.76 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.988 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' OE1' ' A' ' 41' ' ' GLN . 57.4 mt -51.23 -40.64 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.988 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' GLY . 8.6 tt0 -56.78 -60.98 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.136 0.493 . . . . 0.0 110.344 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -49.75 -35.91 23.93 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.743 -178.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -81.46 -39.35 24.96 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -108.54 5.13 24.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.2 19.44 24.3 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.783 178.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.2 mt -88.82 129.34 48.96 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 117.309 0.554 . . . . 0.0 110.662 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.35 131.95 13.23 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.61 1.54 . . . . 0.0 111.992 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.76 -23.08 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.562 2.175 . . . . 0.0 112.98 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.457 ' O ' ' NH1' ' A' ' 74' ' ' ARG . 67.9 m-20 -72.49 -40.21 67.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.841 0.353 . . . . 0.0 111.207 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -84.57 -19.64 32.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.597 -179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' HG21 ' A' ' 30' ' ' ILE . 25.7 tt0 -94.15 137.26 33.54 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.211 0.529 . . . . 0.0 111.546 -179.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -128.98 125.93 38.49 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -99.02 119.07 37.17 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.17 0.51 . . . . 0.0 111.293 -179.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mm -115.89 129.21 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -141.0 123.48 15.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.849 179.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.79 37.36 26.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.08 18.89 69.52 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.232 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -123.95 126.77 46.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.089 0.444 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -76.44 131.08 38.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.086 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.9 mp -68.43 133.38 48.56 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.6 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' GLY . 14.9 tt0 -72.25 131.88 43.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.238 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -62.94 25.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -164.93 16.68 0.1 OUTLIER Glycine 0 CA--C 1.534 1.227 0 C-N-CA 119.473 -1.346 . . . . 0.0 113.761 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -102.03 170.1 8.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.04 0.92 . . . . 0.0 110.921 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -104.3 149.85 24.98 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.214 179.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' TYR . 8.0 mp -57.17 -39.05 74.55 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.422 179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' PRO . 29.0 t -45.65 -38.26 6.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.687 0.28 . . . . 0.0 111.198 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -62.94 -37.79 88.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . 66.3 m-85 -85.32 -5.0 59.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.471 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.98 -38.96 24.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.78 -52.96 53.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -68.84 47.67 0.06 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.27 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.86 61.29 1.01 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.581 0.229 . . . . 0.0 111.298 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.88 -42.21 75.59 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.428 HG23 ' CG ' ' A' ' 68' ' ' HIS . 2.9 t -90.22 178.16 6.23 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -82.59 37.99 0.54 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.101 0.476 . . . . 0.0 111.146 -178.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.428 ' CG ' HG23 ' A' ' 66' ' ' THR . 20.3 m170 -82.33 125.75 31.37 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 70' ' ' VAL . 43.8 tp -111.37 140.36 46.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.423 -179.11 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' H ' HD12 ' A' ' 69' ' ' LEU . 53.9 t -102.78 126.04 57.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 41' ' ' GLN . 2.2 tp -94.5 116.41 28.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.987 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 mmt-85 -103.24 140.61 37.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.653 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.0 mt -115.9 143.14 45.84 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 110.307 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 39' ' ' ASP . 33.0 ttm180 -72.1 -30.74 65.39 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.574 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.49 38.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.715 0 CA-C-O 117.922 -1.488 . . . . 0.0 110.811 -179.887 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -145.55 150.47 36.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.754 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -140.74 145.69 25.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.018 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -96.44 128.62 43.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.56 -179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.1 t -114.47 113.97 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.623 0.725 . . . . 0.0 110.358 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -91.22 107.75 19.42 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.683 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -74.17 167.62 21.22 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.31 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.11 -31.68 68.09 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.192 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.3 p -69.85 -0.39 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.51 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.8 14.66 77.22 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -92.26 120.56 32.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 m -93.36 123.04 36.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.596 0.236 . . . . 0.0 110.827 -179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.465 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 tt -129.93 128.76 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.035 0.445 . . . . 0.0 109.886 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.1 m -83.36 145.28 29.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.381 0.61 . . . . 0.0 111.432 -178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.39 133.79 54.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.552 -178.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -100.52 125.34 46.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.696 HG22 ' H ' ' A' ' 18' ' ' GLU . 14.8 p -155.46 176.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.833 0.825 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.696 ' H ' HG22 ' A' ' 17' ' ' VAL . 97.6 mt-10 -100.32 147.89 34.17 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.402 178.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.72 -21.71 38.41 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.528 1.485 . . . . 0.0 111.987 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.2 t -89.87 0.21 57.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.343 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -67.58 152.73 45.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.102 178.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.2 p -86.15 171.46 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.031 0.443 . . . . 0.0 110.611 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 12.8 mm -72.74 -53.11 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -44.61 -25.3 0.26 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.231 0.539 . . . . 0.0 110.014 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ALA . 35.7 t-20 -73.92 -64.25 1.04 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.494 178.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -45.04 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.489 0.662 . . . . 0.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -72.34 -47.02 52.91 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.441 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.58 -34.44 50.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.593 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -67.43 -63.4 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.789 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.7 mt -50.81 -39.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.988 -179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.9 tt0 -58.45 -61.55 2.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.17 0.51 . . . . 0.0 110.511 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -52.28 -38.14 57.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.894 -178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.62 -38.35 34.05 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -106.94 3.48 26.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 57.11 20.25 34.34 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.784 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.6 mt -95.98 134.21 24.18 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 117.463 0.632 . . . . 0.0 110.717 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.22 122.92 7.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.541 1.494 . . . . 0.0 111.587 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -42.89 -23.88 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.675 2.25 . . . . 0.0 113.217 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -66.99 -34.69 78.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.757 0.313 . . . . 0.0 111.072 -179.529 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -86.01 -11.28 53.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.674 -178.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.24 142.59 31.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.235 0.541 . . . . 0.0 111.99 -179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -128.09 125.17 38.71 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.69 114.97 27.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.562 -178.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -109.71 121.38 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.556 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 46' ' ' ALA . 56.5 t80 -138.34 106.34 5.7 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.471 179.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 66.33 37.04 5.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.7 18.46 68.22 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.1 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -123.26 125.2 44.63 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.961 0.38 . . . . 0.0 110.523 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -76.43 132.06 39.44 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.292 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -70.67 135.76 48.58 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.933 -178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 53' ' ' GLY . 23.6 tt0 -71.96 132.17 43.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.406 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -62.53 17.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -157.12 19.61 0.41 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 119.58 -1.295 . . . . 0.0 113.61 -179.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.46 ' NE ' ' OE1' ' A' ' 51' ' ' GLU . 61.1 mtt180 -106.83 174.57 5.83 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.896 0.848 . . . . 0.0 111.211 179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -107.97 151.8 25.32 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.403 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.6 mp -57.82 -36.97 72.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.265 178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.0 t -46.51 -39.27 10.55 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.544 0.212 . . . . 0.0 111.244 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -64.02 -38.3 90.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' N ' ' O ' ' A' ' 56' ' ' LEU . 81.4 m-85 -84.44 -5.81 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.554 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.8 -45.69 18.31 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.337 0.589 . . . . 0.0 110.021 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -52.89 -49.79 46.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.964 179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -74.83 43.85 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.545 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -81.77 57.63 3.48 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.595 178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -54.19 -30.65 50.45 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.348 -179.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.82 179.53 5.32 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.5 mt -80.94 44.97 0.78 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.295 0.569 . . . . 0.0 110.755 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -84.72 120.84 26.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.061 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.4 tp -113.42 134.98 54.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.363 -179.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' H ' HD12 ' A' ' 69' ' ' LEU . 90.1 t -105.47 127.45 60.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -92.89 118.95 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.125 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.87 143.31 33.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.367 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.0 mp -115.91 138.96 50.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.884 0.373 . . . . 0.0 110.305 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -50.83 110.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.75 163.65 46.12 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.75 0 CA-C-O 117.981 -1.455 . . . . 0.0 110.971 179.912 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' VAL . 62.5 mtm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -144.42 101.37 3.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -99.45 149.31 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -96.68 128.52 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.559 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.7 t -115.27 114.77 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.568 0.699 . . . . 0.0 110.278 179.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -91.04 108.69 20.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.732 -179.44 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 71.6 p -72.89 169.05 17.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.893 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -77.0 -31.12 56.24 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.122 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.9 m -69.88 -1.18 8.75 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.453 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.82 9.63 74.09 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 7' ' ' THR . 67.2 mttm -91.82 112.18 24.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.5 m -94.56 127.76 40.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.19 136.36 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.101 179.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -81.73 144.77 30.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.492 0.663 . . . . 0.0 111.17 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.54 130.7 54.35 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.624 -179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.27 125.29 46.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.708 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.3 p -153.75 175.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.437 0.636 . . . . 0.0 110.909 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.708 ' N ' HG22 ' A' ' 17' ' ' VAL . 50.2 mt-10 -94.97 150.89 38.43 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.414 178.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.39 -24.61 22.5 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 121.358 1.372 . . . . 0.0 112.135 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -90.1 4.84 49.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' OD1' ' CB ' ' A' ' 25' ' ' ASN . 22.2 t0 -70.19 150.09 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.357 178.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.5 p -83.87 168.52 16.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.229 0.537 . . . . 0.0 110.744 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' N ' ' A' ' 25' ' ' ASN . 8.2 mm -71.02 -50.92 39.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.596 178.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 7.3 mm-40 -47.81 -22.23 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.523 0.678 . . . . 0.0 109.633 179.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 28' ' ' ALA . 22.8 t-20 -75.37 -64.13 1.13 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.202 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -44.6 -26.73 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 110.257 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 43.8 mttp -72.12 -47.6 49.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.288 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' ASN . . . -52.72 -33.8 49.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.535 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -67.99 -63.78 0.99 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.68 -36.98 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.974 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' GLY . 40.8 tt0 -58.65 -60.6 3.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.423 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -49.72 -35.7 22.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.704 -178.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -81.15 -43.15 19.79 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -108.53 4.1 23.77 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.96 28.14 47.35 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.645 177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -95.86 109.92 48.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 117.429 0.615 . . . . 0.0 110.861 -179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.5 124.51 8.13 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.883 1.722 . . . . 0.0 111.926 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -44.59 -40.78 14.14 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.599 2.2 . . . . 0.0 113.184 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.12 -33.19 70.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.762 0.315 . . . . 0.0 111.198 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.0 -9.37 59.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.578 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -91.9 133.91 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.892 -179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -121.2 115.25 22.68 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -93.17 116.33 28.92 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.126 0.489 . . . . 0.0 111.351 -178.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -110.18 121.97 63.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.604 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -140.69 119.82 12.85 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.531 179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.82 34.98 25.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.964 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.37 18.33 69.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.25 179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -124.71 127.45 47.29 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.037 0.419 . . . . 0.0 110.602 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -75.73 131.39 39.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.208 178.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.8 mp -70.08 136.94 50.77 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.831 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' GLY . 13.3 tt0 -71.89 132.58 44.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.75 16.72 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -158.4 21.45 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 119.571 -1.3 . . . . 0.0 113.653 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.1 mtt-85 -103.46 172.7 6.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.926 0.863 . . . . 0.0 111.061 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -105.75 150.63 25.35 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.244 179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -57.97 -38.97 77.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.446 178.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -46.51 -39.78 11.42 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.687 0.279 . . . . 0.0 111.454 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -63.02 -36.67 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 56' ' ' LEU . 70.7 m-85 -85.43 -4.07 59.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.88 -35.34 24.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.035 0.445 . . . . 0.0 110.379 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.7 -53.4 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -71.36 46.22 0.11 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.072 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.66 61.51 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.8 0.333 . . . . 0.0 111.576 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -54.55 -36.47 64.37 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.837 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.52 178.88 5.82 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.0 mt -80.37 41.76 0.55 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.201 0.524 . . . . 0.0 110.735 -179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.51 122.16 28.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.932 178.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 70' ' ' VAL . 38.5 tp -114.63 137.8 51.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.282 -178.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' HD12 ' A' ' 69' ' ' LEU . 64.3 t -104.0 124.71 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.49 123.58 36.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -120.24 152.88 37.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.309 179.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 73' ' ' LEU . 11.2 mp -102.7 143.49 32.28 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -68.1 129.92 41.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 110.628 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -48.84 -71.99 0.52 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.755 0 CA-C-O 118.002 -1.443 . . . . 0.0 110.921 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' N ' ' A' ' 2' ' ' GLN . 9.7 tmm? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.609 ' N ' ' SD ' ' A' ' 1' ' ' MET . 11.8 pt20 -145.72 156.01 43.34 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.11 0.481 . . . . 0.0 110.788 179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.6 pt -143.05 146.76 21.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.3 131.76 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.497 -179.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.3 t -112.19 114.12 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.499 0.666 . . . . 0.0 110.295 179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -91.42 107.02 18.92 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.615 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.409 ' HA ' HD21 ' A' ' 71' ' ' LEU . 30.9 p -74.71 169.01 18.72 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.434 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -76.98 -29.93 55.73 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.95 -179.819 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -69.14 -1.37 7.62 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.534 -179.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.55 11.34 71.67 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -91.22 141.67 28.55 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.1 m -115.54 124.06 50.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' ILE . 7.3 tt -131.38 129.89 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.193 0.52 . . . . 0.0 109.782 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -83.33 145.03 29.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.0 111.016 -178.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.99 131.7 54.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.772 -178.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -99.77 123.48 44.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.9 p -153.42 175.77 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.653 0.74 . . . . 0.0 110.909 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.724 ' N ' HG22 ' A' ' 17' ' ' VAL . 25.0 mt-10 -94.94 139.02 21.97 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.235 178.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -68.9 -1.82 8.43 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.455 1.437 . . . . 0.0 112.123 -179.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.0 p -105.29 -23.07 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -51.82 152.63 2.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.221 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -83.05 177.43 8.6 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 110.329 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 mm -72.56 -43.57 62.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.524 178.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -46.12 -26.76 0.81 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.234 0.54 . . . . 0.0 109.738 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -76.04 -62.67 1.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.458 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -45.72 -27.93 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 110.438 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -73.8 -50.19 21.71 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.46 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.25 57.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -67.31 -64.83 0.78 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.631 -0.428 . . . . 0.0 109.889 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.62 -41.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.959 -179.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 35' ' ' GLY . 9.1 tt0 -57.96 -61.2 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.237 0.541 . . . . 0.0 110.185 -179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -48.09 -35.0 10.56 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.581 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.5 -43.56 17.04 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -106.36 5.58 29.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 56.31 27.0 52.13 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.013 178.005 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -97.18 108.59 45.1 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 117.436 0.618 . . . . 0.0 110.65 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.94 150.56 6.54 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.829 1.686 . . . . 0.0 112.219 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.45 -53.41 6.65 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.458 2.105 . . . . 0.0 113.071 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.19 -23.59 67.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.781 0.324 . . . . 0.0 111.08 -179.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -78.87 -27.85 44.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.617 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -99.76 143.88 29.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.157 0.503 . . . . 0.0 112.015 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -123.75 122.34 37.81 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -94.79 118.47 31.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 111.4 -179.049 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -111.98 125.34 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.69 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -138.78 120.97 15.8 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.81 41.14 32.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.967 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.14 17.57 61.51 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.253 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -123.98 128.99 50.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.022 0.411 . . . . 0.0 110.666 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -78.0 132.05 37.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.3 mp -67.32 137.43 56.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.09 0.472 . . . . 0.0 110.751 -178.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.63 147.18 53.62 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.388 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -71.15 17.59 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -171.91 28.92 0.11 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 119.569 -1.301 . . . . 0.0 113.805 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -103.41 168.73 8.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.061 0.93 . . . . 0.0 111.093 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -101.63 148.65 24.99 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 59' ' ' TYR . 7.7 mp -57.07 -39.25 74.59 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 19' ' ' PRO . 58.6 m -44.77 -38.94 4.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.695 0.283 . . . . 0.0 111.188 -179.403 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.13 -37.85 88.83 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' LEU . 71.4 m-85 -84.83 -5.88 59.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.647 -1.161 . . . . 0.0 111.486 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -80.7 -39.24 27.44 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.609 179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' C ' ' H ' ' A' ' 63' ' ' LYS . 96.8 mt -62.13 -49.61 83.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -69.82 47.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 61' ' ' ILE . 56.0 tttm -74.66 61.7 0.99 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -57.12 -42.94 81.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.22 178.25 6.21 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -79.85 44.44 0.64 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.169 0.509 . . . . 0.0 110.767 -178.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -80.98 117.81 21.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -109.53 131.87 54.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.383 -179.077 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.68 ' N ' HD13 ' A' ' 69' ' ' LEU . 55.5 t -111.92 124.27 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' THR . 2.6 pp -105.13 146.84 28.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -142.74 171.44 14.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.152 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 mt -107.46 144.43 34.41 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -58.05 142.2 47.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.78 81.44 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.742 0 CA-C-O 117.983 -1.454 . . . . 0.0 110.827 -179.885 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -148.89 118.24 6.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.778 179.679 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -100.17 148.54 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -98.08 128.95 44.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.676 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.2 t -113.38 116.0 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.364 0.602 . . . . 0.0 110.508 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -92.55 107.15 19.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.569 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -71.77 172.58 9.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.117 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tp -78.99 -27.99 43.44 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.133 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 p -74.86 0.85 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.58 74.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -91.0 122.91 34.06 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -97.62 123.17 41.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.791 -179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' ILE . 5.1 tt -131.75 129.92 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.161 0.505 . . . . 0.0 109.928 179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.6 m -83.94 144.7 28.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.275 -178.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.13 129.37 54.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.704 -179.127 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.29 123.28 38.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.697 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.3 p -153.16 173.74 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.561 0.696 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.697 ' N ' HG22 ' A' ' 17' ' ' VAL . 95.6 mt-10 -98.38 139.0 20.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.449 178.762 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.09 -9.6 22.36 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.592 1.528 . . . . 0.0 112.013 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -94.75 -28.63 15.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.233 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -50.87 148.25 4.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.259 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.33 179.38 7.82 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.355 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mm -73.03 -35.99 49.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.692 179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 6.3 mm-40 -53.2 -27.94 24.21 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.622 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -74.57 -61.05 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.294 178.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -48.14 -26.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.322 0.582 . . . . 0.0 110.235 179.462 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.68 -52.7 10.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.581 179.243 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -34.04 49.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.498 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -67.77 -63.35 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.935 178.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.53 -40.67 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 35' ' ' GLY . 59.8 tt0 -61.94 -60.06 4.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -49.37 -36.92 23.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.992 -179.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -80.98 -40.52 24.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -111.74 5.72 19.32 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -177.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 58.3 14.37 19.19 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.726 178.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.1 mt -85.1 124.07 72.67 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 117.235 0.518 . . . . 0.0 110.736 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.515 ' O ' ' N ' ' A' ' 39' ' ' ASP . 72.1 Cg_endo -76.84 138.24 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.666 1.577 . . . . 0.0 112.133 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -43.0 -14.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.448 2.099 . . . . 0.0 112.888 179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 37' ' ' PRO . 97.4 m-20 -78.84 -39.88 34.24 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.375 -179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -82.41 -26.86 32.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.513 -178.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -102.73 143.5 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.251 0.548 . . . . 0.0 111.802 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NH2' HE22 ' A' ' 49' ' ' GLN . 10.0 mtm180 -132.49 133.27 43.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mt -93.11 115.89 28.51 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.195 0.521 . . . . 0.0 111.417 -179.173 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -111.74 124.97 68.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.545 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -138.04 110.82 7.64 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.637 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.01 40.17 15.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.45 18.93 68.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.301 -0.476 . . . . 0.0 112.123 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -123.45 125.78 45.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.999 0.399 . . . . 0.0 110.699 179.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 HE22 ' NH2' ' A' ' 42' ' ' ARG . 31.0 tt0 -78.61 130.87 36.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 50' ' ' LEU . 7.9 mp -70.38 137.75 50.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.081 0.467 . . . . 0.0 110.803 -178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.0 tt0 -72.06 133.4 45.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.336 -179.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.75 13.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -153.86 20.09 0.68 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 119.687 -1.244 . . . . 0.0 113.695 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -105.03 172.43 6.79 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.986 0.893 . . . . 0.0 111.122 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.1 p -106.75 150.28 26.46 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.158 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.8 mp -57.71 -38.5 75.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.222 178.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 m -45.33 -40.14 7.45 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.643 0.259 . . . . 0.0 111.233 -179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.18 -37.57 85.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.3 m-85 -85.69 -5.34 59.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.592 -1.186 . . . . 0.0 111.546 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 1.1 t-20 -80.9 -39.4 26.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.544 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.1 mt -60.68 -50.33 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.99 48.26 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.849 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -71.87 63.88 0.48 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.625 0.25 . . . . 0.0 111.508 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -58.09 -46.51 85.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.08 0.466 . . . . 0.0 109.894 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.442 ' OG1' ' ND1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -92.48 177.62 6.07 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.736 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.79 41.49 0.5 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.823 -178.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' ND1' ' OG1' ' A' ' 66' ' ' THR . 64.7 m80 -81.4 119.98 24.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.663 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -108.11 133.04 52.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.539 -179.015 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.692 ' N ' HD13 ' A' ' 69' ' ' LEU . 57.0 t -104.49 122.04 56.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.55 120.32 32.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.46 142.69 32.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.387 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 tp -121.19 134.94 55.22 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.514 179.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -77.49 149.33 35.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.516 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.04 54.34 0.33 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.754 0 CA-C-O 118.039 -1.423 . . . . 0.0 110.934 179.949 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 17' ' ' VAL . 33.6 mtm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.05 141.14 32.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.78 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.8 pt -140.66 146.86 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -97.32 129.75 44.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.824 -179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.02 114.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.478 0.656 . . . . 0.0 109.963 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -91.32 105.13 17.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -70.1 168.09 16.32 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pp -77.08 -31.18 55.83 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.155 -179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.4 m -69.87 -13.15 62.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.939 0.4 . . . . 0.0 110.268 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.09 11.54 45.53 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -89.52 114.98 26.59 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -91.01 121.79 33.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.62 -179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 13' ' ' ILE . 6.9 tt -128.97 130.52 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.0 109.769 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -83.87 144.68 29.07 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.316 0.579 . . . . 0.0 111.482 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -123.43 133.57 54.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.933 -179.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -104.06 128.63 51.68 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.687 HG22 ' N ' ' A' ' 18' ' ' GLU . 12.1 p -154.6 175.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.79 0.805 . . . . 0.0 111.031 -179.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.687 ' N ' HG22 ' A' ' 17' ' ' VAL . 4.5 mp0 -93.05 150.37 39.12 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.224 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.43 -31.02 9.47 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.765 1.643 . . . . 0.0 111.872 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.2 p -76.44 -25.31 54.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.256 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.37 147.6 4.26 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.317 0.579 . . . . 0.0 110.778 -179.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -82.81 177.16 8.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.301 179.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' C ' ' N ' ' A' ' 25' ' ' ASN . 9.3 mm -71.23 -46.92 63.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.689 179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 45.9 mm-40 -46.36 -23.11 0.32 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.21 0.529 . . . . 0.0 109.836 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' N ' ' C ' ' A' ' 23' ' ' ILE . 10.2 t-20 -75.03 -62.4 1.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.373 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -47.43 -25.07 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.284 0.564 . . . . 0.0 110.28 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -75.57 -51.48 12.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.982 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.97 -34.38 42.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.512 -179.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -67.53 -63.71 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.003 178.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.466 ' CG2' HE22 ' A' ' 41' ' ' GLN . 54.8 mt -50.47 -39.52 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.282 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 35' ' ' GLY . 58.0 tt0 -58.97 -61.4 2.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.662 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -50.04 -36.9 30.76 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.911 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -81.36 -38.96 25.8 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -108.9 1.47 20.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 55.4 16.72 10.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.789 177.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 57.9 mt -85.46 114.13 54.68 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 117.447 0.624 . . . . 0.0 110.6 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -47.29 122.0 6.01 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.466 1.444 . . . . 0.0 111.806 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -45.42 -39.3 16.63 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.611 2.208 . . . . 0.0 113.388 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -57.99 -31.88 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 111.425 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -83.28 -11.23 57.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.58 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 HE22 ' CG2' ' A' ' 30' ' ' ILE . 12.3 mt-30 -97.85 140.18 32.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.166 0.508 . . . . 0.0 112.233 -178.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -129.98 123.1 29.81 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 44' ' ' ILE . 9.8 mt -92.12 115.28 27.94 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.29 0.567 . . . . 0.0 111.587 -178.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD12 ' C ' ' A' ' 43' ' ' LEU . 1.4 mp -110.05 125.02 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.237 -179.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -141.68 118.21 10.93 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.622 178.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.39 38.33 28.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.101 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.15 18.26 64.67 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.132 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -123.78 127.33 47.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.809 0.305 . . . . 0.0 110.272 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -77.97 131.35 37.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.6 mp -71.12 138.23 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.304 -178.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' GLY . 6.3 tt0 -72.67 133.64 44.71 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.121 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -63.27 31.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.548 -179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -170.93 19.93 0.07 OUTLIER Glycine 0 CA--C 1.531 1.085 0 C-N-CA 119.197 -1.478 . . . . 0.0 113.73 -179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.33 170.59 7.86 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.166 0.983 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.2 p -103.83 149.34 25.14 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.404 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.4 mp -56.95 -39.85 75.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.362 178.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 t -45.65 -39.54 7.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.701 0.286 . . . . 0.0 111.368 -179.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.37 -35.99 79.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' LEU . 47.6 m-85 -86.79 -6.0 58.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.452 179.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -80.62 -38.45 29.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.305 179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.99 -50.71 78.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -69.4 48.5 0.08 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.14 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' NZ ' ' CD2' ' A' ' 67' ' ' LEU . 57.1 tttp -74.49 61.35 0.93 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.52 0.2 . . . . 0.0 111.384 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -56.83 -43.44 81.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.75 178.81 5.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.581 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.5 mm? -81.06 95.61 6.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.325 0.583 . . . . 0.0 110.991 -178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' H ' ' HD1' ' A' ' 68' ' ' HIS . 7.9 p-80 -134.41 119.58 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.694 179.021 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -107.2 133.91 51.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.205 -178.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 69' ' ' LEU . 45.8 t -103.18 121.94 55.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.457 HD11 HE21 ' A' ' 41' ' ' GLN . 18.5 tp -91.27 116.16 28.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -103.06 139.53 38.48 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.7 tp -122.64 132.41 54.26 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -99.11 88.92 4.08 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.445 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 60.57 0.05 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.747 0 CA-C-O 118.033 -1.426 . . . . 0.0 110.897 179.984 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -145.76 98.13 3.08 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.542 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -99.24 150.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.625 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -95.5 122.88 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.783 -179.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.44 114.14 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.38 0.61 . . . . 0.0 109.912 178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -92.73 105.71 17.81 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.202 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -72.03 172.5 9.94 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.361 -0.382 . . . . 0.0 109.974 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.99 -35.12 64.41 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.044 -179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 9' ' ' THR . 89.3 m -69.21 -11.69 61.02 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.47 -179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.77 15.38 43.05 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -88.61 116.08 26.6 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.9 m -89.48 119.32 29.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.469 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 13' ' ' ILE . 6.8 tt -130.35 129.75 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 110.019 179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.7 m -83.46 143.85 29.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.384 0.611 . . . . 0.0 111.065 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.93 130.38 54.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.775 -179.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.46 122.24 37.98 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 18' ' ' GLU . 3.0 p -149.81 168.93 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.481 0.658 . . . . 0.0 110.762 -179.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.616 ' N ' HG22 ' A' ' 17' ' ' VAL . 36.4 mt-10 -94.5 141.04 22.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.42 179.2 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -66.6 -6.47 15.43 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.37 1.38 . . . . 0.0 112.259 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 55' ' ' THR . 13.2 m -100.36 -26.05 14.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.174 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -50.47 146.59 5.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.027 0.442 . . . . 0.0 110.582 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -82.65 178.93 7.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.174 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' C ' ' N ' ' A' ' 25' ' ' ASN . 10.0 mm -72.67 -44.96 59.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.534 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -45.21 -23.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.341 0.591 . . . . 0.0 109.635 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 23' ' ' ILE . 38.6 t30 -78.81 -59.69 2.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.381 178.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -48.63 -28.07 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.231 0.539 . . . . 0.0 110.426 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -71.97 -51.53 21.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.511 179.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.7 59.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.795 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -67.42 -65.79 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.239 179.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -52.2 -41.64 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.194 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 35' ' ' GLY . 21.9 tm0? -61.41 -59.8 4.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 110.303 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -49.79 -34.77 20.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.696 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -84.36 -44.78 13.43 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.51 0.59 31.22 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 54.08 30.82 47.53 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.704 177.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.9 mt -93.83 110.59 48.48 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 117.516 0.658 . . . . 0.0 111.054 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.37 124.8 12.51 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.808 1.672 . . . . 0.0 112.002 179.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -43.64 -39.51 10.03 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.528 2.152 . . . . 0.0 112.865 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.47 -29.32 69.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 0.0 110.958 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -79.27 -23.53 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.47 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -110.8 151.15 28.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -179.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HE ' HH11 ' A' ' 72' ' ' ARG . 56.8 mtm-85 -130.09 130.09 44.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 mt -90.94 117.37 29.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.16 0.505 . . . . 0.0 111.437 -178.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.1 mm -113.61 121.91 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.523 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -140.66 125.06 17.68 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.712 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.51 33.41 18.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.88 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.31 16.91 69.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.186 179.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HZ2' ' NE2' ' A' ' 62' ' ' GLN . 95.5 mttt -124.63 130.81 53.13 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.077 0.439 . . . . 0.0 110.641 179.433 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -75.28 130.68 39.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.007 178.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 50' ' ' LEU . 8.0 mp -68.26 131.9 46.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 110.829 -178.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' GLY . 19.9 tt0 -68.1 135.89 52.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.222 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -60.77 15.08 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . -163.77 26.05 0.2 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.828 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -104.42 168.6 8.99 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.911 0.855 . . . . 0.0 111.236 179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 20' ' ' SER . 40.0 p -101.63 149.15 24.42 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.341 179.528 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.7 mp -57.53 -37.06 72.44 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.309 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.4 t -47.1 -38.7 11.85 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 120.721 0.296 . . . . 0.0 111.294 -179.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.39 -36.91 85.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 72.8 m-85 -86.38 -4.45 59.17 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.509 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -83.12 -38.56 22.26 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.382 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.13 -52.12 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.459 ' NE2' ' HZ2' ' A' ' 48' ' ' LYS . 40.7 mt-30 -70.85 46.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.984 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -82.3 58.77 4.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.576 179.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -53.18 -32.8 49.78 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.3 177.09 5.48 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.6 99.35 8.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.332 0.586 . . . . 0.0 111.104 -178.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -143.03 124.68 14.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.908 179.11 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 70' ' ' VAL . 32.6 tp -109.47 134.47 51.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.173 -179.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' H ' HD12 ' A' ' 69' ' ' LEU . 46.8 t -104.69 126.3 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.48 116.81 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.212 0.53 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.521 HH11 ' HE ' ' A' ' 42' ' ' ARG . 14.1 mtm180 -102.32 144.89 30.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.404 178.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 tp -122.49 131.72 53.99 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -59.04 117.33 4.57 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.68 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.55 -13.32 0.09 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.737 0 CA-C-O 118.004 -1.442 . . . . 0.0 110.917 -179.928 . . . . . . . . 0 0 . 1 stop_ save_